相關文章
Related Articles詳細介紹
品牌 | 其他品牌 | 供貨周期 | 現貨 |
---|---|---|---|
應用領域 | 醫療衛生,環保,化工,生物產業,制藥 |
Cayman公司成立于1980年,在過去20多年的發展過程中,始終保持著為全球科研工作者提供高質、優價研究產品的宗旨。該公司目前可以提供 2,138 多種生化和免疫試劑,涉及腫瘤、氧化氮、神經學、凋亡、氧化性損傷、內分泌學等研究領域。非常有特色的包括類花生酸類物質、游離的生物標志、環核苷、激素及氧化氮等。此外,還提供多種高質量試劑,如類花生酸類物質、氧化氮試劑及許多相關脂質、脂肪酸、酶和抗體等。Cayman非常愿意接受各地客戶的要求,合成復雜和不穩定分子。
Cayman CAC-10011247-1 CAY10574
Cayman CAC-10011247-1 CAY10574
Cayman CAC-10009435-500 Leukotriene B4 Express AChE Tracer 500 dtn 10087
Cayman CAC-10009436-1 Leukotriene B4 Express Standard 1 ea 446.6
Cayman CAC-10009437-1 Kifunensine 1 mg 1216.6
Cayman CAC-10009437-10 Kifunensine 10 mg 7915.6
Cayman CAC-10009437-5 Kifunensine 5 mg 5482.4
Cayman CAC-10009437-50 Kifunensine 50 mg 24332
Cayman CAC-10009439-1 Bergamottin 1 mg 385
Cayman CAC-10009439-10 Bergamottin 10 mg 3080
Cayman CAC-10009439-5 Bergamottin 5 mg 1740.2
Cayman CAC-10009445-1 Glucoraphanin 1 mg 385
Cayman CAC-10009445-10 Glucoraphanin 10 mg 3064.6
Cayman CAC-10009445-5 Glucoraphanin 5 mg 1740.2
Cayman CAC-10009458-1 JTE-013 1 mg 292.6
Cayman CAC-10009458-10 JTE-013 10 mg 2340.8
Cayman CAC-10009458-5 JTE-013 5 mg 1324.4
Cayman CAC-10009458-50 JTE-013 50 mg 10241
Cayman CAC-10009465-1 HDAC6 (human recombinant) 1 ea 7945.8
Cayman CAC-10009466-1 HDAC9 (human recombinant) 1 ea 7945.8
Cayman CAC-10009473-100 1,2-Dipalmitoyl-sn-glycero-3-PC 100 mg 985.6
Cayman CAC-10009473-25 1,2-Dipalmitoyl-sn-glycero-3-PC 25 mg 308
Cayman CAC-10009473-250 1,2-Dipalmitoyl-sn-glycero-3-PC 250 mg 1848
Cayman CAC-10009473-50 1,2-Dipalmitoyl-sn-glycero-3-PC 50 mg 554.4
Cayman CAC-10009488-1 TF CREB (Phospho-Ser133) Competitor dsDNA 1 ea 754.6
Cayman CAC-10009489-1 TF CREB (Phospho-Ser133) 96-Well Strip Plate 1 ea 1416.8
Cayman CAC-10009501-100 20-hydroxy N-Arachidonoyl Taurine 100 µg 6591.2
Cayman CAC-10009501-25 20-hydroxy N-Arachidonoyl Taurine 25 µg 1832.6
Cayman CAC-10009501-50 20-hydroxy N-Arachidonoyl Taurine 50 µg 3480.4
Cayman CAC-10009501-500 20-hydroxy N-Arachidonoyl Taurine 500 µg 29321.6
Cayman CAC-10009504-1 Raf-1 (Phospho-Ser301) Polyclonal Antibody 1 ea 6831
Cayman CAC-10009505-1 Raf-1 (Phospho-Ser642) Polyclonal Antibody 1 ea 6831
Cayman CAC-10009506-1 PSD95 Polyclonal Antibody 1 ea 6831
Cayman CAC-10009517-1 MEK1 (Phospho-Thr386) Polyclonal Antibody 1 ea 6831
Cayman CAC-10009518-1 MEK1 (Phospho-Thr292) Polyclonal Antibody 1 ea 6831
Cayman CAC-10009523-1 CAY10429-d3 1 mg 3819.2
Cayman CAC-10009523-100 CAY10429-d3 100 µg 477.4
Cayman CAC-10009523-5 CAY10429-d3 5 mg 16709
Cayman CAC-10009523-500 CAY10429-d3 500 µg 2156
Cayman CAC-10009531-10 PtdIns-(3,4,5)-P3-biotin (sodium salt) 10 µg 1986.6
Cayman CAC-10009531-100 PtdIns-(3,4,5)-P3-biotin (sodium salt) 100 µg 12920.6
Cayman CAC-10009531-25 PtdIns-(3,4,5)-P3-biotin (sodium salt) 25 µg 4712.4
Cayman CAC-10009531-50 PtdIns-(3,4,5)-P3-biotin (sodium salt) 50 µg 8146.6
Cayman CAC-10009532-10 (±)8(9)-EET-d11 10 µg 1509.2
Cayman CAC-10009532-25 (±)8(9)-EET-d11 25 µg 3588.2
Cayman CAC-10009532-50 (±)8(9)-EET-d11 50 µg 6791.4
Cayman CAC-10009536-10 CAY10512 10 mg 508.2
Cayman CAC-10009536-100 CAY10512 100 mg 4065.6
Cayman CAC-10009536-50 CAY10512 50 mg 2294.6
Cayman CAC-10009536-500 CAY10512 500 mg 17787
Cayman CAC-10009542-10 Anhydrotetracycline (hydrochloride) 10 mg 385
Cayman CAC-10009542-100 Anhydrotetracycline (hydrochloride) 100 mg 2125.2
Cayman CAC-10009542-25 Anhydrotetracycline (hydrochloride) 25 mg 816.2
Cayman CAC-10009542-50 Anhydrotetracycline (hydrochloride) 50 mg 1355.2
Cayman CAC-10009547-100 FABP1 (human recombinant) 100 µg 4989
Cayman CAC-10009548-100 FABP2 (human recombinant) 100 µg 4989
Cayman CAC-10009549-100 FABP4 (human recombinant) 100 µg 4989
Cayman CAC-10009551-100 FABP7 (human recombinant) 100 µg 4989
Cayman CAC-10009557-1 SC-1 1 mg 693
Cayman CAC-10009557-10 SC-1 10 mg 3465
Cayman CAC-10009557-25 SC-1 25 mg 7623
Cayman CAC-10009557-5 SC-1 5 mg 1909.6
Cayman CAC-10009563-25 sPLA2 (human recombinant Type V) 25 µg 5528
Cayman CAC-10009569-1 (R)-Roscovitine 1 mg 492.8
Cayman CAC-10009569-10 (R)-Roscovitine 10 mg 3665.2
Cayman CAC-10009569-5 (R)-Roscovitine 5 mg 2094.4
Cayman CAC-10009569-500 (R)-Roscovitine 500 µg 261.8
Cayman CAC-10009570-1 SecinH3 1 mg 600.6
Cayman CAC-10009570-10 SecinH3 10 mg 3003
Cayman CAC-10009570-25 SecinH3 25 mg 6006
Cayman CAC-10009570-5 SecinH3 5 mg 1801.8
Cayman CAC-10009581-1 PCSK9 (mouse) Blocking Peptide 1 ea 1647.8
Cayman CAC-10009582-2 Glucose Colorimetric Assay Kit 2 x 96 wells 2695
Cayman CAC-10009584-100 2,3-dinor Thromboxane B2-d9 100 µg 8208.2
Cayman CAC-10009584-25 2,3-dinor Thromboxane B2-d9 25 µg 2279.2
Cayman CAC-10009584-50 2,3-dinor Thromboxane B2-d9 50 µg 4327.4
Cayman CAC-10009591-1 MTT Reagent 1 ea 554.4
Cayman CAC-10009591-5 MTT Reagent 5 ea 2079
Cayman CAC-10009594-10 Pyocyanin 10 mg 1986.6
Cayman CAC-10009594-100 Pyocyanin 100 mg 11303.6
Cayman CAC-10009594-5 Pyocyanin 5 mg 1047.2
Cayman CAC-10009594-50 Pyocyanin 50 mg 6699
Cayman CAC-10009598-1 6,7-dihydroxy Bergamottin 1 mg 231
Cayman CAC-10009598-10 6,7-dihydroxy Bergamottin 10 mg 1848
Cayman CAC-10009598-25 6,7-dihydroxy Bergamottin 25 mg 4050.2
Cayman CAC-10009598-5 6,7-dihydroxy Bergamottin 5 mg 1047.2
Cayman CAC-10009599-10 Calcipotriol (hydrate) 10 mg 862.4
Cayman CAC-10009599-100 Calcipotriol (hydrate) 100 mg 6899.2
Cayman CAC-10009599-50 Calcipotriol (hydrate) 50 mg 3880.8
Cayman CAC-10009599-500 Calcipotriol (hydrate) 500 mg 30184
Cayman CAC-10009610-1 Lomitapide 1 mg 677.6
Cayman CAC-10009610-10 Lomitapide 10 mg 5420.8
Cayman CAC-10009610-5 Lomitapide 5 mg 2879.8
Cayman CAC-10009628-100 5(S),6(R)-11-trans DiHETE 100 µg 5374
Cayman CAC-10009628-25 5(S),6(R)-11-trans DiHETE 25 µg 1924.4
Cayman CAC-10009628-50 5(S),6(R)-11-trans DiHETE 50 µg 3110.2
Cayman CAC-10009634-1 Purmorphamine 1 mg 338.8
Cayman CAC-10009634-10 Purmorphamine 10 mg 2710.4
Cayman CAC-10009634-25 Purmorphamine 25 mg 5929
Cayman CAC-10009634-5 Purmorphamine 5 mg 1524.6
Cayman CAC-10009642-1 SOTS-1 (technical grade) 1 mg 1139
Cayman CAC-10009642-10 SOTS-1 (technical grade) 10 mg 4450
Cayman CAC-10009642-5 SOTS-1 (technical grade) 5 mg 2910
Cayman CAC-10009642-500 SOTS-1 (technical grade) 500 µg 985
Cayman CAC-10009644-1 BAY 43-9006 1 mg 385
Cayman CAC-10009644-10 BAY 43-9006 10 mg 1155
Cayman CAC-10009644-5 BAY 43-9006 5 mg 770
Cayman CAC-10009644-50 BAY 43-9006 50 mg 3665.2
Cayman CAC-10009645-1 Maslinic Acid 1 mg 323.4
Cayman CAC-10009645-10 Maslinic Acid 10 mg 2587.2
Cayman CAC-10009645-25 Maslinic Acid 25 mg 5667.2
Cayman CAC-10009645-5 Maslinic Acid 5 mg 1463
Cayman CAC-10009650-1 (+)-AS 115 1 mg 5790.4
Cayman CAC-10009650-100 (+)-AS 115 100 µg 723.8
Cayman CAC-10009650-500 (+)-AS 115 500 µg 3264.8
Cayman CAC-10009651-1 2-thio-Acetyl MAGE 1 mg 1077.4
Cayman CAC-10009651-10 2-thio-Acetyl MAGE 10 mg 4419.2
Cayman CAC-10009651-25 2-thio-Acetyl MAGE 25 mg 8962.2
Cayman CAC-10009651-5 2-thio-Acetyl MAGE 5 mg 2756
Cayman CAC-10009652-1 HDAC4 (human recombinant) 1 ea 7945.8
Cayman CAC-10009658-96 Cayman Practice ELISA Kit 96 wells 862.4
Cayman CAC-10009660-1 CYPMPO 1 mg 785.4
Cayman CAC-10009660-10 CYPMPO 10 mg 6283.2
Cayman CAC-10009660-5 CYPMPO 5 mg 3542
Cayman CAC-10009661-10 N-Octadecyl-N'-propyl-sulfamide 10 mg 1786.4
Cayman CAC-10009661-25 N-Octadecyl-N'-propyl-sulfamide 25 mg 4235
Cayman CAC-10009661-5 N-Octadecyl-N'-propyl-sulfamide 5 mg 939.4
Cayman CAC-10009661-50 N-Octadecyl-N'-propyl-sulfamide 50 mg 7515.2
Cayman CAC-10009667-1 Glycerol Tridocosahexaenoyl 1 mg 385
Cayman CAC-10009667-10 Glycerol Tridocosahexaenoyl 10 mg 1386
Cayman CAC-10009667-25 Glycerol Tridocosahexaenoyl 25 mg 2079
Cayman CAC-10009667-5 Glycerol Tridocosahexaenoyl 5 mg 1155
Cayman CAC-10009729-100 Ricinoleic Acid methyl ester 100 mg 385
Cayman CAC-10009729-1 Ricinoleic Acid methyl ester 1 g 1278.2
Cayman CAC-10009729-500 Ricinoleic Acid methyl ester 500 mg 862.4
Cayman CAC-10009730-1 Ricinoleic Acid ethyl ester 1 g 1078
Cayman CAC-10009730-500 Ricinoleic Acid ethyl ester 500 mg 600.6
Cayman CAC-10009732-1 Glycerol Trieicosapentaenoyl 1 mg 385
Cayman CAC-10009732-10 Glycerol Trieicosapentaenoyl 10 mg 1386
Cayman CAC-10009732-25 Glycerol Trieicosapentaenoyl 25 mg 2079
Cayman CAC-10009732-5 Glycerol Trieicosapentaenoyl 5 mg 1155
Cayman CAC-10009733-1 5(Z),8(Z),14(Z)-Eicosatrienoic Acid 1 mg 5513.2
Cayman CAC-10009733-100 5(Z),8(Z),14(Z)-Eicosatrienoic Acid 100 µg 847
Cayman CAC-10009733-500 5(Z),8(Z),14(Z)-Eicosatrienoic Acid 500 µg 2972.2
Cayman CAC-10009746-50 PTEN (human recombinant) 50 µg 5066
Cayman CAC-10009758-10 Glycerol Tri-α-Linolenoyl 10 mg 385
Cayman CAC-10009758-100 Glycerol Tri-α-Linolenoyl 100 mg 2510.2
Cayman CAC-10009758-50 Glycerol Tri-α-Linolenoyl 50 mg 1447.6
Cayman CAC-10009759-1 NMDA Receptor NR2B Subunit (Phospho-Tyr1252) Polyclonal Antibody 1 ea 6831
Cayman CAC-10009760-1 NMDA Receptor NR2B Subunit (Phospho-Tyr1336) Polyclonal Antibody 1 ea 6831
Cayman CAC-10009761-1 NMDA Receptor NR2B Subunit (Phospho-Tyr1472) Polyclonal Antibody 1 ea 6831
Cayman CAC-10009762-1 Progesterone Receptor (Phospho-Ser190) Monoclonal Antibody 1 ea 6831
Cayman CAC-10009763-1 Progesterone Receptor (Phospho-Ser294) Monoclonal Antibody 1 ea 6831
Cayman CAC-10009768-1 LY293111 1 mg 2510.2
Cayman CAC-10009768-10 LY293111 10 mg 18541.6
Cayman CAC-10009768-5 LY293111 5 mg 10595.2
Cayman CAC-10009768-500 LY293111 500 µg 1324.4
Cayman CAC-10009779-2 Cholesterol Cell-Based Detection Assay Kit 2 x 96 wells 3630
Cayman CAC-10009785-1 Dynamin (Phospho-Ser774) Polyclonal Antibody 1 ea 6831
Cayman CAC-10009786-1 Dynamin (Phospho-Ser778) Polyclonal Antibody 1 ea 6831
Cayman CAC-10009795-1 Taranabant 1 mg 1031.8
Cayman CAC-10009795-10 Taranabant 10 mg 7546
Cayman CAC-10009795-5 Taranabant 5 mg 4312
Cayman CAC-10009795-500 Taranabant 500 µg 539
Cayman CAC-10009796-10 CAY10602 10 mg 677.6
Cayman CAC-10009796-100 CAY10602 100 mg 4958.8
Cayman CAC-10009796-5 CAY10602 5 mg 354.2
Cayman CAC-10009796-50 CAY10602 50 mg 2833.6
Cayman CAC-10009797-1 CAY10591 1 mg 785.4
Cayman CAC-10009797-10 CAY10591 10 mg 6283.2
Cayman CAC-10009797-25 CAY10591 25 mg 13752.2
Cayman CAC-10009797-5 CAY10591 5 mg 3542
Cayman CAC-10009798-1 EX-527 1 mg 385
Cayman CAC-10009798-10 EX-527 10 mg 1155
Cayman CAC-10009798-25 EX-527 25 mg 2510.2
Cayman CAC-10009798-5 EX-527 5 mg 708.4
Cayman CAC-10009799-100 17(S)-HDHA 100 µg 5097.4
Cayman CAC-10009799-25 17(S)-HDHA 25 µg 1416.8
Cayman CAC-10009799-250 17(S)-HDHA 250 µg 11334.4
Cayman CAC-10009799-50 17(S)-HDHA 50 µg 2695
Cayman CAC-10009804-100 3-PT-PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) 100 µg 2664.2
Cayman CAC-10009804-25 3-PT-PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) 25 µg 739.2
Cayman CAC-10009804-250 3-PT-PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) 250 µg 5913.6
Cayman CAC-10009804-50 3-PT-PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) 50 µg 1401.4
Cayman CAC-10009813-1 thio-Miltefosine 1 mg 400.4
Cayman CAC-10009813-10 thio-Miltefosine 10 mg 3203.2
Cayman CAC-10009813-25 thio-Miltefosine 25 mg 7007
Cayman CAC-10009813-5 thio-Miltefosine 5 mg 1801.8
Cayman CAC-10009815-100 PtdIns-(4,5)-P2 Binding Protein 100 µg 5697.4
Cayman CAC-10009815-25 PtdIns-(4,5)-P2 Binding Protein 25 µg 2016.8
Cayman CAC-10009815-50 PtdIns-(4,5)-P2 Binding Protein 50 µg 3295
Cayman CAC-10009816-1 (+)-Nutlin-3 1 mg 908.6
Cayman CAC-10009816-10 (+)-Nutlin-3 10 mg 4096.4
Cayman CAC-10009816-25 (+)-Nutlin-3 25 mg 9086
Cayman CAC-10009816-5 (+)-Nutlin-3 5 mg 2279.2
Cayman CAC-10009817-100 PtdIns-(3,4,5)-P3 Binding Protein 100 µg 5697.4
Cayman CAC-10009817-25 PtdIns-(3,4,5)-P3 Binding Protein 25 µg 2016.8
Cayman CAC-10009817-50 PtdIns-(3,4,5)-P3 Binding Protein 50 µg 3295
Cayman CAC-10009818-25 NF-κB (p50) (human recombinant) 25 µg 5605
Cayman CAC-10009825-10 Glycerol Tri-γ-Linolenoyl 10 mg 1201.2
Cayman CAC-10009825-100 Glycerol Tri-γ-Linolenoyl 100 mg 4204.2
Cayman CAC-10009825-5 Glycerol Tri-γ-Linolenoyl 5 mg 631.4
Cayman CAC-10009825-50 Glycerol Tri-γ-Linolenoyl 50 mg 3003
Cayman CAC-10009826-10 Glycerol Triarachidonoyl 10 mg 693
Cayman CAC-10009826-100 Glycerol Triarachidonoyl 100 mg 3003
Cayman CAC-10009826-25 Glycerol Triarachidonoyl 25 mg 1524.6
Cayman CAC-10009826-5 Glycerol Triarachidonoyl 5 mg 385
Cayman CAC-10009831-1 Protein Carbonyl Homogenization Buffer (10X) 1 ea 246.4
Cayman CAC-10009832-100 (±)12(13)-DiHOME 100 µg 1386
Cayman CAC-10009832-25 (±)12(13)-DiHOME 25 µg 385
Cayman CAC-10009832-50 (±)12(13)-DiHOME 50 µg 739.2
Cayman CAC-10009832-500 (±)12(13)-DiHOME 500 µg 6160
Cayman CAC-10009835-1 MK-0524 1 mg 693
Cayman CAC-10009835-10 MK-0524 10 mg 3126.2
Cayman CAC-10009835-25 MK-0524 25 mg 6930
Cayman CAC-10009835-5 MK-0524 5 mg 1740.2
Cayman CAC-10009846-96 CREB (Phospho-Ser133) Transcription Factor Assay Kit 96 wells 7145
Cayman CAC-10009848-1 TF CREB (Phospho-Ser133) Primary Antibody 1 ea 1617
Cayman CAC-10009849-1 TF CREB (Phospho-Ser133) Positive Control 1 ea 2016.8
Cayman CAC-10009851-1 D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) 1 mg 6036.8
Cayman CAC-10009851-100 D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) 100 µg 754.6
Cayman CAC-10009851-500 D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) 500 µg 3403.4
Cayman CAC-10009853-100 CFSE Cell Division Assay Kit 100 tests 2233
Cayman CAC-10009854-10 Resolvin E1-d4 10 µg 3332.4
Cayman CAC-10009854-25 Resolvin E1-d4 25 µg 6757.8
Cayman CAC-10009857-1 JTE-907 1 mg 754.6
Cayman CAC-10009857-5 JTE-907 5 mg 3018.4
Cayman CAC-10009864-10 1-Stearoyl-2-Arachidonoyl PC 10 mg 1801.8
Cayman CAC-10009864-25 1-Stearoyl-2-Arachidonoyl PC 25 mg 3603.6
Cayman CAC-10009864-5 1-Stearoyl-2-Arachidonoyl PC 5 mg 1001
Cayman CAC-10009866-1 Cell-Based Assay Wash Buffer 1 ea 169.4
Cayman CAC-10009867-1 Cholesterol Detection Filipin III 1 ea 2310
Cayman CAC-10009868-1 Cholesterol Detection Assay Buffer 1 ea 169.4
Cayman CAC-10009869-1 Cell-Based Assay U-18666A 1 ea 785.4
Cayman CAC-10009870-1 CD36 Monoclonal FITC Antibody (Clone JC63.1) 1 ea 4450.6
Cayman CAC-10009871-1 Palmitoleic Acid 1 g 2340.8
Cayman CAC-10009871-100 Palmitoleic Acid 100 mg 292.6
Cayman CAC-10009871-5 Palmitoleic Acid 5 g 10241
Cayman CAC-10009871-500 Palmitoleic Acid 500 mg 1324.4
Cayman CAC-10009872-1 1-Stearoyl-2-Arachidonoyl-sn-Glycerol-d8 1 mg 6144
Cayman CAC-10009872-100 1-Stearoyl-2-Arachidonoyl-sn-Glycerol-d8 100 µg 1293
Cayman CAC-10009872-500 1-Stearoyl-2-Arachidonoyl-sn-Glycerol-d8 500 µg 3726.2
Cayman CAC-10009874-10 1,2-Dioctanoyl PC 10 mg 323.4
Cayman CAC-10009874-25 1,2-Dioctanoyl PC 25 mg 770
Cayman CAC-10009874-5 1,2-Dioctanoyl PC 5 mg 169.4
Cayman CAC-10009874-50 1,2-Dioctanoyl PC 50 mg 1355.2
Cayman CAC-10009875-1 16-phenoxy Prostaglandin F2α ethyl amide 1 mg 1139.6
Cayman CAC-10009875-10 16-phenoxy Prostaglandin F2α ethyl amide 10 mg 8408.4
Cayman CAC-10009875-5 16-phenoxy Prostaglandin F2α ethyl amide 5 mg 4804.8
Cayman CAC-10009879-10 1,2-Didecanoyl PC 10 mg 323.4
Cayman CAC-10009879-25 1,2-Didecanoyl PC 25 mg 770
Cayman CAC-10009879-5 1,2-Didecanoyl PC 5 mg 169.4
Cayman CAC-10009879-50 1,2-Didecanoyl PC 50 mg 1355.2
Cayman CAC-10009880-1 GW 590735 1 mg 662.2
Cayman CAC-10009880-10 GW 590735 10 mg 5297.6
Cayman CAC-10009880-25 GW 590735 25 mg 11596.2
Cayman CAC-10009880-5 GW 590735 5 mg 2987.6
Cayman CAC-10009893-100 CD36 Monoclonal Antibody (Clone JC63.1) (azide free) 100 µg 3988.6
Cayman CAC-10009893-500 CD36 Monoclonal Antibody (Clone JC63.1) (azide free) 500 µg 12243
Cayman CAC-10009898-1 (-)-11-nor-9-carboxy-Δ9-THC-d3 (exempt preparation) 1 mg 6036.8
Cayman CAC-10009898-100 (-)-11-nor-9-carboxy-Δ9-THC-d3 (exempt preparation) 100 µg 754.6
Cayman CAC-10009898-500 (-)-11-nor-9-carboxy-Δ9-THC-d3 (exempt preparation) 500 µg 3403.4
Cayman CAC-10009899-1 Cell-Based Assay Fixative 1 ea 477.4
Cayman CAC-10009906-1 Cell-Based Assay Blocking Solution 1 ea 400.4
Cayman CAC-10009908-1 JC-1 Assay Reagent 1 ea 2510.2
Cayman CAC-10009911-1 Tangeritin 1 mg 154
Cayman CAC-10009911-100 Tangeritin 100 mg 9240
Cayman CAC-10009911-5 Tangeritin 5 mg 693
Cayman CAC-10009911-50 Tangeritin 50 mg 5390
Cayman CAC-10009926-96 Phosphatidylcholine Colorimetric Assay Kit 96 wells 3911.6
Cayman CAC-10009928-96 Sphingomyelin Colorimetric Assay Kit 96 wells 3911.6
Cayman CAC-10009929-1 SAHA 1 g 2340.8
Cayman CAC-10009929-100 SAHA 100 mg 292.6
Cayman CAC-10009929-250 SAHA 250 mg 693
Cayman CAC-10009929-500 SAHA 500 mg 1324.4
Cayman CAC-10009931-1 24(S)-hydroxy Cholesterol 1 mg 847
Cayman CAC-10009931-10 24(S)-hydroxy Cholesterol 10 mg 7623
Cayman CAC-10009931-5 24(S)-hydroxy Cholesterol 5 mg 4019.4
Cayman CAC-10009948-1 Adipolysis Assay IBMX Solution (1,000X) 1 ea 631.4
Cayman CAC-10009950-1 Adipolysis Assay Dexamethasone Solution (1,000X) 1 ea 631.4
Cayman CAC-10009951-1 Adipolysis Assay Isoproterenol Solution 1 ea 631.4
Cayman CAC-10009952-1 Glycerol Standard Solution 1 ea 939.4
Cayman CAC-10009957-1 Propidium Iodide Reagent 1 ea 1262.8
Cayman CAC-10009959-1 RNase A Solution 1 ea 1262.8
Cayman CAC-10009962-100 2-(14,15-Epoxyeicosatrienoyl) Glycerol 100 µg 11303
Cayman CAC-10009962-25 2-(14,15-Epoxyeicosatrienoyl) Glycerol 25 µg 3572.2
Cayman CAC-10009962-50 2-(14,15-Epoxyeicosatrienoyl) Glycerol 50 µg 6251.8
Cayman CAC-10009965-1 VO-OHpic (hydrate) 1 mg 385
Cayman CAC-10009965-10 VO-OHpic (hydrate) 10 mg 1740.2
Cayman CAC-10009965-25 VO-OHpic (hydrate) 25 mg 3850
Cayman CAC-10009965-5 VO-OHpic (hydrate) 5 mg 1155
Cayman CAC-10009984-10 (±)5(6)-EET-d11 10 µg 2109.2
Cayman CAC-10009984-25 (±)5(6)-EET-d11 25 µg 4188.2
Cayman CAC-10009984-50 (±)5(6)-EET-d11 50 µg 7391.4
Cayman CAC-10009986-1 Dimethoxycurcumin 1 mg 338.8
Cayman CAC-10009986-10 Dimethoxycurcumin 10 mg 2032.8
Cayman CAC-10009986-5 Dimethoxycurcumin 5 mg 1355.2
Cayman CAC-10009992-1 Zeaxanthin 1 mg 3480.4
Cayman CAC-10009992-500 Zeaxanthin 500 µg 1832.6
Cayman CAC-10009993-100 (±)9(10)-DiHOME-d4 100 µg 4158
Cayman CAC-10009993-25 (±)9(10)-DiHOME-d4 25 µg 1155
Cayman CAC-10009993-50 (±)9(10)-DiHOME-d4 50 µg 2202.2
Cayman CAC-10009993-500 (±)9(10)-DiHOME-d4 500 µg 18480
Cayman CAC-10009994-100 (±)12(13)-DiHOME-d4 100 µg 4158
Cayman CAC-10009994-25 (±)12(13)-DiHOME-d4 25 µg 1155
Cayman CAC-10009994-250 (±)12(13)-DiHOME-d4 250 µg 9240
Cayman CAC-10009994-50 (±)12(13)-DiHOME-d4 50 µg 2202.2
Cayman CAC-10009995-100 (±)9(10)-EpOME-d4 100 µg 4989.6
Cayman CAC-10009995-25 (±)9(10)-EpOME-d4 25 µg 1386
Cayman CAC-10009995-250 (±)9(10)-EpOME-d4 250 µg 11088
Cayman CAC-10009995-50 (±)9(10)-EpOME-d4 50 µg 2633.4
Cayman CAC-10009996-100 (±)12(13)-EpOME-d4 100 µg 4989.6
Cayman CAC-10009996-25 (±)12(13)-EpOME-d4 25 µg 1386
Cayman CAC-10009996-250 (±)12(13)-EpOME-d4 250 µg 11088
Cayman CAC-10009996-50 (±)12(13)-EpOME-d4 50 µg 2633.4
Cayman CAC-10009998-100 (±)8,9-DiHET-d11 100 µg 8208.2
Cayman CAC-10009998-25 (±)8,9-DiHET-d11 25 µg 2279.2
Cayman CAC-10009998-250 (±)8,9-DiHET-d11 250 µg 18233.6
Cayman CAC-10009998-50 (±)8,9-DiHET-d11 50 µg 4327.4
Cayman CAC-10009999-1 5(Z),11(Z),14(Z)-Eicosatrienoic Acid 1 mg 5513.2
Cayman CAC-10009999-100 5(Z),11(Z),14(Z)-Eicosatrienoic Acid 100 µg 847
Cayman CAC-10009999-500 5(Z),11(Z),14(Z)-Eicosatrienoic Acid 500 µg 2972.2
Cayman CAC-10010-1 Prostaglandin A1 1 mg 539
Cayman CAC-10010-10 Prostaglandin A1 10 mg 3080
Cayman CAC-10010-5 Prostaglandin A1 5 mg 1755.6
Cayman CAC-10010-50 Prostaglandin A1 50 mg 12135.2
Cayman CAC-10010005-250 Cysteinyl Leukotriene Column Elution Solvent 250 ml 1617
Cayman CAC-10010005-50 Cysteinyl Leukotriene Column Elution Solvent 50 ml 431.2
Cayman CAC-10010013-1 Glutathione S-Transferase Polyclonal Antibody 1 ea 3988.6
Cayman CAC-10010016-1 (+)-Cloprostenol isopropyl ester 1 mg 893.2
Cayman CAC-10010016-10 (+)-Cloprostenol isopropyl ester 10 mg 7145.6
Cayman CAC-10010016-5 (+)-Cloprostenol isopropyl ester 5 mg 4019.4
Cayman CAC-10010019-500 FABP2 Polyclonal Antibody 500 µl 3988.6
Cayman CAC-10010020-1 FABP2 Blocking Peptide 1 ea 1647.8
Cayman CAC-10010024-1 LY223982 1 mg 323.4
Cayman CAC-10010024-10 LY223982 10 mg 2587.2
Cayman CAC-10010024-25 LY223982 25 mg 5667.2
Cayman CAC-10010024-5 LY223982 5 mg 1463
Cayman CAC-10010032-1 CAY10570 1 mg 677.6
Cayman CAC-10010032-10 CAY10570 10 mg 4958.8
Cayman CAC-10010032-5 CAY10570 5 mg 2833.6
Cayman CAC-10010032-500 CAY10570 500 µg 354.2
Cayman CAC-10010043-1 CAY10561 1 mg 585.2
Cayman CAC-10010043-10 CAY10561 10 mg 4312
Cayman CAC-10010043-5 CAY10561 5 mg 2464
Cayman CAC-10010043-500 CAY10561 500 µg 308
Cayman CAC-10010061-1 17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide 1 mg 908.6
Cayman CAC-10010061-10 17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide 10 mg 7268.8
Cayman CAC-10010061-5 17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide 5 mg 4096.4
Cayman CAC-10010061-50 17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide 50 mg 31801
Cayman CAC-10010062-1 17-trifluoromethylphenyl trinor Prostaglandin F2α isopropyl ester 1 mg 693
Cayman CAC-10010062-10 17-trifluoromethylphenyl trinor Prostaglandin F2α isopropyl ester 10 mg 5544
Cayman CAC-10010062-5 17-trifluoromethylphenyl trinor Prostaglandin F2α isopropyl ester 5 mg 3126.2
Cayman CAC-10010063-1 15(S)-15-methyl Prostaglandin F2α isopropyl ester 1 mg 600.6
Cayman CAC-10010063-10 15(S)-15-methyl Prostaglandin F2α isopropyl ester 10 mg 4804.8
Cayman CAC-10010063-5 15(S)-15-methyl Prostaglandin F2α isopropyl ester 5 mg 2710.4
Cayman CAC-10010064-1 15(S)-15-methyl Prostaglandin F2α ethyl amide 1 mg 1078
Cayman CAC-10010064-10 15(S)-15-methyl Prostaglandin F2α ethyl amide 10 mg 8624
Cayman CAC-10010064-5 15(S)-15-methyl Prostaglandin F2α ethyl amide 5 mg 4851
Cayman CAC-10010066-1 PC Buffer (10X) 1 ea 169.4
Cayman CAC-10010067-1 PC Color Detector 1 ea 400.4
Cayman CAC-10010068-1 PC Enzyme Mixture 1 ea 400.4
Cayman CAC-10010069-1 PC-Specific Phospholipase D 1 ea 1570.8
Cayman CAC-10010070-1 Phosphatidylcholine Standard 1 ea 631.4
Cayman CAC-10010071-1 PC Detergent Solution 1 ea 169.4
Cayman CAC-10010073-1 SM Color Detector 1 ea 323.4
Cayman CAC-10010074-1 SM Enzyme Mixture 1 ea 400.4
Cayman CAC-10010075-1 SM Alkaline Phosphatase 1 ea 323.4
Cayman CAC-10010076-1 Sphingomyelinase 1 ea 1570.8
Cayman CAC-10010088-1 CAY10526 1 mg 693
Cayman CAC-10010088-10 CAY10526 10 mg 5544
Cayman CAC-10010088-5 CAY10526 5 mg 3126.2
Cayman CAC-10010089-1 Inotilone 1 mg 539
Cayman CAC-10010089-10 Inotilone 10 mg 3773
Cayman CAC-10010089-25 Inotilone 25 mg 8085
Cayman CAC-10010089-5 Inotilone 5 mg 2017.4
Cayman CAC-10010093-1 1-Oleoyl Lysophosphatidic Acid 1 mg 231
Cayman CAC-10010093-10 1-Oleoyl Lysophosphatidic Acid 10 mg 1848
Cayman CAC-10010093-25 1-Oleoyl Lysophosphatidic Acid 25 mg 4050.2
Cayman CAC-10010093-5 1-Oleoyl Lysophosphatidic Acid 5 mg 1047.2
Cayman CAC-10010094-1 1-Palmitoyl Lysophosphatidic Acid 1 mg 477.4
Cayman CAC-10010094-10 1-Palmitoyl Lysophosphatidic Acid 10 mg 3819.2
Cayman CAC-10010094-25 1-Palmitoyl Lysophosphatidic Acid 25 mg 8362.2
Cayman CAC-10010094-5 1-Palmitoyl Lysophosphatidic Acid 5 mg 2156
Cayman CAC-10010096-1 COX-2 (mouse) Polyclonal FITC Antibody 1 ea 4450.6
Cayman CAC-10010098-1 Glucose Assay Standard 1 ea 585.2
Cayman CAC-10010100-1 Glucose Colorimetric Enzyme Mixture 1 ea 431.2
Cayman CAC-10010101-10 11-cis Vaccenyl Acetate 10 mg 523.6
Cayman CAC-10010101-100 11-cis Vaccenyl Acetate 100 mg 3880.8
Cayman CAC-10010101-5 11-cis Vaccenyl Acetate 5 mg 277.2
Cayman CAC-10010101-50 11-cis Vaccenyl Acetate 50 mg 2217.6
Cayman CAC-10010102-1 16-phenoxy tetranor Prostaglandin F2α methyl ester 1 mg 1293.6
Cayman CAC-10010102-5 16-phenoxy tetranor Prostaglandin F2α methyl ester 5 mg 5420.8
Cayman CAC-10010102-500 16-phenoxy tetranor Prostaglandin F2α methyl ester 500 µg 677.6
Cayman CAC-10010103-1 16-phenoxy tetranor Prostaglandin F2α isopropyl ester 1 mg 1262.8
Cayman CAC-10010103-10 16-phenoxy tetranor Prostaglandin F2α isopropyl ester 10 mg 9132.2
Cayman CAC-10010103-5 16-phenoxy tetranor Prostaglandin F2α isopropyl ester 5 mg 5297.6
Cayman CAC-10010103-500 16-phenoxy tetranor Prostaglandin F2α isopropyl ester 500 µg 662.2
Cayman CAC-10010109-100 8-DY547-cGMP 100 µg 3572.8
Cayman CAC-10010109-50 8-DY547-cGMP 50 µg 1878.8
Cayman CAC-10010110-1 17-phenyl trinor Prostaglandin F2α methyl ester 1 mg 908.6
Cayman CAC-10010110-10 17-phenyl trinor Prostaglandin F2α methyl ester 10 mg 7268.8
Cayman CAC-10010110-5 17-phenyl trinor Prostaglandin F2α methyl ester 5 mg 4096.4
Cayman CAC-10010111-1 17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester 1 mg 708.4
Cayman CAC-10010111-10 17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester 10 mg 5667.2
Cayman CAC-10010111-5 17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester 5 mg 3187.8
Cayman CAC-10010112-1 Ptd(S)Ins-(3,4)-P2 (1,2-dipalmitoyl) (sodium salt) 1 mg 7392
Cayman CAC-10010112-100 Ptd(S)Ins-(3,4)-P2 (1,2-dipalmitoyl) (sodium salt) 100 µg 924
Cayman CAC-10010112-500 Ptd(S)Ins-(3,4)-P2 (1,2-dipalmitoyl) (sodium salt) 500 µg 4158
Cayman CAC-10010115-1 (+)-Cloprostenol methyl ester 1 mg 893.2
Cayman CAC-10010115-10 (+)-Cloprostenol methyl ester 10 mg 7145.6
Cayman CAC-10010115-5 (+)-Cloprostenol methyl ester 5 mg 4019.4
Cayman CAC-10010116-1 CB-25 1 mg 385
Cayman CAC-10010116-10 CB-25 10 mg 2895.2
Cayman CAC-10010116-5 CB-25 5 mg 1509.2
Cayman CAC-10010117-1 CB-52 1 mg 385
Cayman CAC-10010117-10 CB-52 10 mg 3080
Cayman CAC-10010117-5 CB-52 5 mg 1740.2
Cayman CAC-10010117-50 CB-52 50 mg 13475
Cayman CAC-10010118-1 AM1241 1 mg 385
Cayman CAC-10010118-10 AM1241 10 mg 1740.2
Cayman CAC-10010118-25 AM1241 25 mg 3850
Cayman CAC-10010118-5 AM1241 5 mg 970.2
Cayman CAC-10010123-100 Prostaglandin D2-d9 100 µg 3542
Cayman CAC-10010123-25 Prostaglandin D2-d9 25 µg 985.6
Cayman CAC-10010123-50 Prostaglandin D2-d9 50 µg 1878.8
Cayman CAC-10010129-1 AG-041R 1 mg 554.4
Cayman CAC-10010129-10 AG-041R 10 mg 4435.2
Cayman CAC-10010129-5 AG-041R 5 mg 2494.8
Cayman CAC-10010129-50 AG-041R 50 mg 19404
Cayman CAC-10010132-1 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester 1 mg 5404.8
Cayman CAC-10010132-100 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester 100 µg 1200.6
Cayman CAC-10010132-500 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester 500 µg 3310.4
Cayman CAC-10010146-1 Soluble Epoxide Hydrolase Polyclonal Antibody 1 ea 3988.6
Cayman CAC-10010147-1 Soluble Epoxide Hydrolase Blocking Peptide 1 ea 1647.8
Cayman CAC-10010151-1 Fluprostenol methyl ester 1 mg 862.4
Cayman CAC-10010151-10 Fluprostenol methyl ester 10 mg 6899.2
Cayman CAC-10010151-5 Fluprostenol methyl ester 5 mg 3880.8
Cayman CAC-10010164-1 1-Octadecyl Lysophosphatidic Acid 1 mg 523.6
Cayman CAC-10010164-10 1-Octadecyl Lysophosphatidic Acid 10 mg 3880.8
Cayman CAC-10010164-5 1-Octadecyl Lysophosphatidic Acid 5 mg 2217.6
Cayman CAC-10010164-500 1-Octadecyl Lysophosphatidic Acid 500 µg 277.2
Cayman CAC-10010172-1 (R)-Equol 1 mg 200.2
Cayman CAC-10010172-10 (R)-Equol 10 mg 1601.6
Cayman CAC-10010172-25 (R)-Equol 25 mg 3511.2
Cayman CAC-10010172-5 (R)-Equol 5 mg 908.6
Cayman CAC-10010173-1 (S)-Equol 1 mg 246.4
Cayman CAC-10010173-10 (S)-Equol 10 mg 1971.2
Cayman CAC-10010173-25 (S)-Equol 25 mg 4312
Cayman CAC-10010173-5 (S)-Equol 5 mg 1108.8
Cayman CAC-10010175-1 AS-604850 1 mg 308
Cayman CAC-10010175-10 AS-604850 10 mg 2464
Cayman CAC-10010175-25 AS-604850 25 mg 5390
Cayman CAC-10010175-5 AS-604850 5 mg 1386
Cayman CAC-10010177-1 PI3-Kinase α Inhibitor 2 1 mg 616
Cayman CAC-10010177-10 PI3-Kinase α Inhibitor 2 10 mg 4527.6
Cayman CAC-10010177-5 PI3-Kinase α Inhibitor 2 5 mg 2587.2
Cayman CAC-10010177-500 PI3-Kinase α Inhibitor 2 500 µg 323.4
Cayman CAC-10010180-10 cis-12-Octadecenoic Acid methyl ester 10 mg 970.2
Cayman CAC-10010180-5 cis-12-Octadecenoic Acid methyl ester 5 mg 508.2
Cayman CAC-10010180-50 cis-12-Octadecenoic Acid methyl ester 50 mg 4065.6
Cayman CAC-10010181-1 Ptd(S)Ins-(3,4)-P2 (1,2-dioctanoyl) (sodium salt) 1 mg 7392
Cayman CAC-10010181-100 Ptd(S)Ins-(3,4)-P2 (1,2-dioctanoyl) (sodium salt) 100 µg 924
Cayman CAC-10010181-500 Ptd(S)Ins-(3,4)-P2 (1,2-dioctanoyl) (sodium salt) 500 µg 4158
Cayman CAC-10010183-100 Fatty Acid Amide Hydrolase (human recombinant) 100 units 7376
Cayman CAC-10010188-1 1-Hexadecyl Lysophosphatidic Acid 1 mg 477.4
Cayman CAC-10010188-10 1-Hexadecyl Lysophosphatidic Acid 10 mg 3819.2
Cayman CAC-10010188-25 1-Hexadecyl Lysophosphatidic Acid 25 mg 8362.2
Cayman CAC-10010188-5 1-Hexadecyl Lysophosphatidic Acid 5 mg 2156
Cayman CAC-10010199-480 WST-8 Cell Proliferation Assay Kit 480 wells 1509.2
Cayman CAC-10010199-96 WST-8 Cell Proliferation Assay Kit 96 wells 770
Cayman CAC-10010200-480 XTT Cell Proliferation Assay Kit 480 wells 1509.2
Cayman CAC-10010200-96 XTT Cell Proliferation Assay Kit 96 wells 770
Cayman CAC-10010206-1 BMS309403 1 mg 539
Cayman CAC-10010206-10 BMS309403 10 mg 1894.2
Cayman CAC-10010206-25 BMS309403 25 mg 4050.2
Cayman CAC-10010206-5 BMS309403 5 mg 1078
Cayman CAC-10010208-1 Active Caspase-3/7 Substrate N-Ac-DEVD-N'-MC-R110 1 ea 1185.8
Cayman CAC-10010209-1 Active Caspase-3 Positive Control 1 ea 1385.4
Cayman CAC-10010210-1 Caspase-3/7 Inhibitor N-Ac-DEVD-CHO 1 ea 785.4
Cayman CAC-10010215-1 Cell-Based Assay Lysis Buffer 1 ea 169.4
Cayman CAC-10010219-10 1,8-ANS 10 g 446.6
Cayman CAC-10010219-100 1,8-ANS 100 g 3234
Cayman CAC-10010219-5 1,8-ANS 5 g 231
Cayman CAC-10010219-50 1,8-ANS 50 g 1848
Cayman CAC-10010228-1 Lyso-PAF C-18 -d4 1 mg 2587.2
Cayman CAC-10010228-100 Lyso-PAF C-18 -d4 100 µg 323.4
Cayman CAC-10010228-500 Lyso-PAF C-18 -d4 500 µg 1463
Cayman CAC-10010229-1 PAF C-18-d4 1 mg 2340.8
Cayman CAC-10010229-100 PAF C-18-d4 100 µg 292.6
Cayman CAC-10010229-500 PAF C-18-d4 500 µg 1324.4
Cayman CAC-10010231-1 FABP4 Inhibitor/Ligand Screening Assay Kit 1 ea 4511.6
Cayman CAC-10010233-1 CAY10567 1 g 2464
Cayman CAC-10010233-100 CAY10567 100 mg 323.4
Cayman CAC-10010233-250 CAY10567 250 mg 770
Cayman CAC-10010233-500 CAY10567 500 mg 1463
Cayman CAC-10010235-1 Terreic Acid 1 mg 847
Cayman CAC-10010235-5 Terreic Acid 5 mg 3388
Cayman CAC-10010236-10 ML-9 10 mg 693
Cayman CAC-10010236-100 ML-9 100 mg 4158
Cayman CAC-10010236-250 ML-9 250 mg 7792.4
Cayman CAC-10010236-50 ML-9 50 mg 2772
Cayman CAC-10010237-1 Triciribine 1 mg 1801.8
Cayman CAC-10010237-10 Triciribine 10 mg 14414.4
Cayman CAC-10010237-5 Triciribine 5 mg 8115.8
Cayman CAC-10010238-1 Erbstatin analog 1 mg 138.6
Cayman CAC-10010238-10 Erbstatin analog 10 mg 1108.8
Cayman CAC-10010238-5 Erbstatin analog 5 mg 631.4
Cayman CAC-10010238-50 Erbstatin analog 50 mg 4851
Cayman CAC-10010239-1 Kenpaullone 1 mg 600.6
Cayman CAC-10010239-10 Kenpaullone 10 mg 2279.2
Cayman CAC-10010239-25 Kenpaullone 25 mg 4958.8
Cayman CAC-10010239-5 Kenpaullone 5 mg 1509.2
Cayman CAC-10010240-1 Olomoucine 1 mg 385
Cayman CAC-10010240-10 Olomoucine 10 mg 1540
Cayman CAC-10010240-25 Olomoucine 25 mg 3372.6
Cayman CAC-10010240-5 Olomoucine 5 mg 862.4
Cayman CAC-10010241-100 AICAR 100 mg 1247.4
Cayman CAC-10010241-250 AICAR 250 mg 2772
Cayman CAC-10010241-50 AICAR 50 mg 693
Cayman CAC-10010241-500 AICAR 500 mg 4851
Cayman CAC-10010242-10 AG-494 10 mg 785.4
Cayman CAC-10010242-25 AG-494 25 mg 1878.8
Cayman CAC-10010242-5 AG-494 5 mg 415.8
Cayman CAC-10010242-50 AG-494 50 mg 3326.4
Cayman CAC-10010243-1 AG-825 1 mg 385
Cayman CAC-10010243-10 AG-825 10 mg 1740.2
Cayman CAC-10010243-5 AG-825 5 mg 1355.2
Cayman CAC-10010243-50 AG-825 50 mg 6745.2
Cayman CAC-10010244-1 AG-1478 1 mg 261.8
Cayman CAC-10010244-10 AG-1478 10 mg 2094.4
Cayman CAC-10010244-25 AG-1478 25 mg 4589.2
Cayman CAC-10010244-5 AG-1478 5 mg 1185.8
Cayman CAC-10010246-10 SB-216763 10 mg 1724.8
Cayman CAC-10010246-100 SB-216763 100 mg 12720.4
Cayman CAC-10010246-5 SB-216763 5 mg 908.6
Cayman CAC-10010246-50 SB-216763 50 mg 7268.8
Cayman CAC-10010247-1 SB-415286 1 mg 616
Cayman CAC-10010247-10 SB-415286 10 mg 4527.6
Cayman CAC-10010247-5 SB-415286 5 mg 2587.2
Cayman CAC-10010247-500 SB-415286 500 µg 323.4
Cayman CAC-10010248-10 AG-17 10 mg 616
Cayman CAC-10010248-25 AG-17 25 mg 1463
Cayman CAC-10010248-5 AG-17 5 mg 323.4
Cayman CAC-10010248-50 AG-17 50 mg 2587.2
Cayman CAC-10010249-10 H-8 (hydrochloride) 10 mg 585.2
Cayman CAC-10010249-25 H-8 (hydrochloride) 25 mg 1355.2
Cayman CAC-10010249-5 H-8 (hydrochloride) 5 mg 385
Cayman CAC-10010249-50 H-8 (hydrochloride) 50 mg 2310
Cayman CAC-10010250-1 Cellular Retinol Binding Protein 7 Polyclonal Antibody 1 ea 3988.6
Cayman CAC-10010251-1 Cellular Retinol Binding Protein 7 Blocking Peptide 1 ea 1647.8
Cayman CAC-10010252-10 Methyl-L-NIO (hydrochloride) 10 mg 1493.8
Cayman CAC-10010252-25 Methyl-L-NIO (hydrochloride) 25 mg 3542
Cayman CAC-10010252-5 Methyl-L-NIO (hydrochloride) 5 mg 785.4
Cayman CAC-10010252-50 Methyl-L-NIO (hydrochloride) 50 mg 6283.2
Cayman CAC-10010254-1 Pentosidine 1 mg 3003
Cayman CAC-10010254-10 Pentosidine 10 mg 24024
Cayman CAC-10010254-5 Pentosidine 5 mg 13521.2
Cayman CAC-10010255-1 5-(galactosylhydroxy)-L-Lysine 1 mg 600.6
Cayman CAC-10010255-10 5-(galactosylhydroxy)-L-Lysine 10 mg 4804.8
Cayman CAC-10010255-5 5-(galactosylhydroxy)-L-Lysine 5 mg 2710.4
Cayman CAC-10010255-50 5-(galactosylhydroxy)-L-Lysine 50 mg 21021
Cayman CAC-10010260-100 Rofecoxib 100 mg 1694
Cayman CAC-10010260-250 Rofecoxib 250 mg 3988.6
Cayman CAC-10010260-50 Rofecoxib 50 mg 1062.6
Cayman CAC-10010260-500 Rofecoxib 500 mg 6375.6
Cayman CAC-10010263-1 RIPA Buffer Concentrate 1 ea 446.6
Cayman CAC-10010265-10 LFM-A13 10 mg 1617
Cayman CAC-10010265-100 LFM-A13 100 mg 11858
Cayman CAC-10010265-5 LFM-A13 5 mg 847
Cayman CAC-10010265-50 LFM-A13 50 mg 6776
Cayman CAC-10010266-10 BAY 11-7082 10 mg 1139.6
Cayman CAC-10010266-25 BAY 11-7082 25 mg 2710.4
Cayman CAC-10010266-5 BAY 11-7082 5 mg 600.6
Cayman CAC-10010266-50 BAY 11-7082 50 mg 4804.8
Cayman CAC-10010267-10 SC-514 10 mg 970.2
Cayman CAC-10010267-25 SC-514 25 mg 2294.6
Cayman CAC-10010267-5 SC-514 5 mg 539
Cayman CAC-10010267-50 SC-514 50 mg 4050.2
Cayman CAC-10010268-1 Lavendustin A 1 mg 1001
Cayman CAC-10010268-10 Lavendustin A 10 mg 4004
Cayman CAC-10010268-5 Lavendustin A 5 mg 2248.4
Cayman CAC-10010275-100 Apigenin 100 mg 2664.2
Cayman CAC-10010275-25 Apigenin 25 mg 739.2
Cayman CAC-10010275-50 Apigenin 50 mg 1401.4
Cayman CAC-10010275-500 Apigenin 500 mg 11827.2
Cayman CAC-10010279-1 Palmitate (calcium salt) 1 g 862.4
Cayman CAC-10010279-100 Palmitate (calcium salt) 100 mg 107.8
Cayman CAC-10010279-5 Palmitate (calcium salt) 5 g 3773
Cayman CAC-10010279-500 Palmitate (calcium salt) 500 mg 492.8
Cayman CAC-10010290-1 1-Palmitoyl Lysophosphatidic Acid (sodium salt) 1 mg 477.4
Cayman CAC-10010290-10 1-Palmitoyl Lysophosphatidic Acid (sodium salt) 10 mg 3819.2
Cayman CAC-10010290-25 1-Palmitoyl Lysophosphatidic Acid (sodium salt) 25 mg 8362.2
Cayman CAC-10010290-5 1-Palmitoyl Lysophosphatidic Acid (sodium salt) 5 mg 2156
Cayman CAC-10010291-1 1-Octadecyl Lysophosphatidic Acid (sodium salt) 1 mg 508.2
Cayman CAC-10010291-10 1-Octadecyl Lysophosphatidic Acid (sodium salt) 10 mg 4065.6
Cayman CAC-10010291-25 1-Octadecyl Lysophosphatidic Acid (sodium salt) 25 mg 8901.2
Cayman CAC-10010291-5 1-Octadecyl Lysophosphatidic Acid (sodium salt) 5 mg 2294.6
Cayman CAC-10010292-1 1-Hexadecyl Lysophosphatidic Acid (sodium salt) 1 mg 492.8
Cayman CAC-10010292-10 1-Hexadecyl Lysophosphatidic Acid (sodium salt) 10 mg 3665.2
Cayman CAC-10010292-5 1-Hexadecyl Lysophosphatidic Acid (sodium salt) 5 mg 2094.4
Cayman CAC-10010292-500 1-Hexadecyl Lysophosphatidic Acid (sodium salt) 500 µg 261.8
Cayman CAC-10010293-1 Palmitoyl 3-carbacyclic Phosphatidic Acid 1 mg 1786.4
Cayman CAC-10010293-10 Palmitoyl 3-carbacyclic Phosphatidic Acid 10 mg 13151.6
Cayman CAC-10010293-5 Palmitoyl 3-carbacyclic Phosphatidic Acid 5 mg 7515.2
Cayman CAC-10010293-500 Palmitoyl 3-carbacyclic Phosphatidic Acid 500 µg 939.4
Cayman CAC-10010298-1 Palmitoleoyl 3-carbacyclic Phosphatidic Acid 1 mg 1786.4
Cayman CAC-10010298-10 Palmitoleoyl 3-carbacyclic Phosphatidic Acid 10 mg 13151.6
Cayman CAC-10010298-5 Palmitoleoyl 3-carbacyclic Phosphatidic Acid 5 mg 7515.2
Cayman CAC-10010298-500 Palmitoleoyl 3-carbacyclic Phosphatidic Acid 500 µg 939.4
Cayman CAC-10010299-1 Oleoyl 3-carbacyclic Phosphatidic Acid 1 mg 1786.4
Cayman CAC-10010299-10 Oleoyl 3-carbacyclic Phosphatidic Acid 10 mg 13151.6
Cayman CAC-10010299-5 Oleoyl 3-carbacyclic Phosphatidic Acid 5 mg 7515.2
Cayman CAC-10010299-500 Oleoyl 3-carbacyclic Phosphatidic Acid 500 µg 939.4
Cayman CAC-10010300-10 AG-18 10 mg 785.4
Cayman CAC-10010300-25 AG-18 25 mg 1878.8
Cayman CAC-10010300-5 AG-18 5 mg 415.8
Cayman CAC-10010300-50 AG-18 50 mg 3326.4
Cayman CAC-10010301-10 CAY10554 10 mg 1493.8
Cayman CAC-10010301-25 CAY10554 25 mg 3542
Cayman CAC-10010301-5 CAY10554 5 mg 785.4
Cayman CAC-10010301-50 CAY10554 50 mg 6283.2
Cayman CAC-10010302-10 DRB 10 mg 369.6
Cayman CAC-10010302-100 DRB 100 mg 2956.8
Cayman CAC-10010302-250 DRB 250 mg 6468
Cayman CAC-10010302-50 DRB 50 mg 1663.2
Cayman CAC-10010303-96 Triglyceride Colorimetric Assay Kit 96 wells 3049.2
Cayman CAC-10010309-10 RG-13022 10 mg 1339.8
Cayman CAC-10010309-5 RG-13022 5 mg 708.4
Cayman CAC-10010309-50 RG-13022 50 mg 5667.2
Cayman CAC-10010310-10 RG-14620 10 mg 1339.8
Cayman CAC-10010310-5 RG-14620 5 mg 708.4
Cayman CAC-10010310-50 RG-14620 50 mg 5667.2
Cayman CAC-10010311-10 AG-490 10 mg 785.4
Cayman CAC-10010311-25 AG-490 25 mg 1878.8
Cayman CAC-10010311-5 AG-490 5 mg 415.8
Cayman CAC-10010311-50 AG-490 50 mg 3326.4
Cayman CAC-10010312-10 AG-82 10 mg 616
Cayman CAC-10010312-25 AG-82 25 mg 1463
Cayman CAC-10010312-5 AG-82 5 mg 323.4
Cayman CAC-10010312-50 AG-82 50 mg 2587.2
Cayman CAC-10010313-10 AG-99 10 mg 785.4
Cayman CAC-10010313-25 AG-99 25 mg 1878.8
Cayman CAC-10010313-5 AG-99 5 mg 415.8
Cayman CAC-10010313-50 AG-99 50 mg 3326.4
Cayman CAC-10010314-10 AG-213 10 mg 1324.4
Cayman CAC-10010314-25 AG-213 25 mg 3126.2
Cayman CAC-10010314-5 AG-213 5 mg 693
Cayman CAC-10010314-50 AG-213 50 mg 5544
Cayman CAC-10010315-10 AG-183 10 mg 939.4
Cayman CAC-10010315-25 AG-183 25 mg 2217.6
Cayman CAC-10010315-5 AG-183 5 mg 492.8
Cayman CAC-10010315-50 AG-183 50 mg 3942.4
Cayman CAC-10010317-1 FABP Assay Buffer (10X) 1 ea 323.4
Cayman CAC-10010318-1 FABP4 (human recombinant) Assay Reagent (5X) 1 ea 2170.8
Cayman CAC-10010322-1 Normal Rabbit IgG-FITC 1 ea 1570.8
Cayman CAC-10010324-1 Harmine 1 g 1155
Cayman CAC-10010324-250 Harmine 250 mg 385
Cayman CAC-10010324-500 Harmine 500 mg 693
Cayman CAC-10010329-1 Lavendustin C 1 mg 308
Cayman CAC-10010329-10 Lavendustin C 10 mg 2464
Cayman CAC-10010329-5 Lavendustin C 5 mg 1386
Cayman CAC-10010329-50 Lavendustin C 50 mg 10780
Cayman CAC-10010332-1 AMP-Deoxynojirimycin 1 mg 1001
Cayman CAC-10010332-10 AMP-Deoxynojirimycin 10 mg 7330.4
Cayman CAC-10010332-5 AMP-Deoxynojirimycin 5 mg 4188.8
Cayman CAC-10010332-500 AMP-Deoxynojirimycin 500 µg 523.6
Cayman CAC-10010333-1 Misoprostol (free acid)-d5 1 mg 4281.2
Cayman CAC-10010333-100 Misoprostol (free acid)-d5 100 µg 1386
Cayman CAC-10010333-50 Misoprostol (free acid)-d5 50 µg 893.2
Cayman CAC-10010334-10 Fluvastatin 10 mg 446.6
Cayman CAC-10010334-100 Fluvastatin 100 mg 2910.6
Cayman CAC-10010334-25 Fluvastatin 25 mg 1001
Cayman CAC-10010334-50 Fluvastatin 50 mg 1678.6
Cayman CAC-10010337-10 Fluvastatin (sodium salt) 10 mg 308
Cayman CAC-10010337-100 Fluvastatin (sodium salt) 100 mg 1817.2
Cayman CAC-10010337-25 Fluvastatin (sodium salt) 25 mg 677.6
Cayman CAC-10010337-50 Fluvastatin (sodium salt) 50 mg 1016.4
Cayman CAC-10010338-10 Lovastatin 10 mg 462
Cayman CAC-10010338-5 Lovastatin 5 mg 308
Cayman CAC-10010338-50 Lovastatin 50 mg 1078
Cayman CAC-10010339-1 Lovastatin Hydroxy Acid (sodium salt) 1 mg 446.6
Cayman CAC-10010339-10 Lovastatin Hydroxy Acid (sodium salt) 10 mg 1663.2
Cayman CAC-10010339-25 Lovastatin Hydroxy Acid (sodium salt) 25 mg 3850
Cayman CAC-10010339-5 Lovastatin Hydroxy Acid (sodium salt) 5 mg 1232
Cayman CAC-10010340-10 Mevastatin 10 mg 554.4
Cayman CAC-10010340-25 Mevastatin 25 mg 847
Cayman CAC-10010340-5 Mevastatin 5 mg 308
Cayman CAC-10010340-50 Mevastatin 50 mg 985.6
Cayman CAC-10010342-10 Pravastatin 10 mg 446.6
Cayman CAC-10010342-100 Pravastatin 100 mg 2910.6
Cayman CAC-10010342-25 Pravastatin 25 mg 1001
Cayman CAC-10010342-50 Pravastatin 50 mg 1678.6
Cayman CAC-10010343-10 Pravastatin (sodium salt) 10 mg 554.4
Cayman CAC-10010343-25 Pravastatin (sodium salt) 25 mg 847
Cayman CAC-10010343-5 Pravastatin (sodium salt) 5 mg 308
Cayman CAC-10010343-50 Pravastatin (sodium salt) 50 mg 985.6
Cayman CAC-10010344-100 Simvastatin 100 mg 1663.2
Cayman CAC-10010344-25 Simvastatin 25 mg 693
Cayman CAC-10010344-5 Simvastatin 5 mg 385
Cayman CAC-10010344-50 Simvastatin 50 mg 1047.2
Cayman CAC-10010345-1 Simvastatin (sodium salt) 1 mg 431.2
Cayman CAC-10010345-10 Simvastatin (sodium salt) 10 mg 3449.6
Cayman CAC-10010345-25 Simvastatin (sodium salt) 25 mg 7546
Cayman CAC-10010345-5 Simvastatin (sodium salt) 5 mg 1940.4
Cayman CAC-10010350-10 CCG-1423 10 mg 877.8
Cayman CAC-10010350-25 CCG-1423 25 mg 2079
Cayman CAC-10010350-5 CCG-1423 5 mg 462
Cayman CAC-10010350-50 CCG-1423 50 mg 3696
Cayman CAC-10010351-1 17-phenyl trinor Prostaglandin F2α methyl amide 1 mg 693
Cayman CAC-10010351-10 17-phenyl trinor Prostaglandin F2α methyl amide 10 mg 4512.2
Cayman CAC-10010351-5 17-phenyl trinor Prostaglandin F2α methyl amide 5 mg 3126.2
Cayman CAC-10010351-50 17-phenyl trinor Prostaglandin F2α methyl amide 50 mg 11257.4
Cayman CAC-10010353-1 XTT Reagent (powder) 1 ea 631.4
Cayman CAC-10010353-5 XTT Reagent (powder) 5 ea 2371.6
Cayman CAC-10010355-1 CJ-023423 1 mg 847
Cayman CAC-10010355-10 CJ-023423 10 mg 6776
Cayman CAC-10010355-25 CJ-023423 25 mg 14830.2
Cayman CAC-10010355-5 CJ-023423 5 mg 3819.2
Cayman CAC-10010364-100 FABP5 (human recombinant) 100 µg 4989
Cayman CAC-10010367-1 ZM 336372 1 mg 385
Cayman CAC-10010367-10 ZM 336372 10 mg 1617
Cayman CAC-10010367-25 ZM 336372 25 mg 3557.4
Cayman CAC-10010367-5 ZM 336372 5 mg 908.6
Cayman CAC-10010368-1 GW 5074 1 mg 446.6
Cayman CAC-10010368-10 GW 5074 10 mg 2233
Cayman CAC-10010368-25 GW 5074 25 mg 5020.4
Cayman CAC-10010368-5 GW 5074 5 mg 1447.6
Cayman CAC-10010372-1 GW 842166X 1 mg 261.8
Cayman CAC-10010372-10 GW 842166X 10 mg 2109.8
Cayman CAC-10010372-25 GW 842166X 25 mg 4019.4
Cayman CAC-10010372-5 GW 842166X 5 mg 1185.8
Cayman CAC-10010375-1 5-Iodotubercidin 1 mg 1201.2
Cayman CAC-10010375-100 5-Iodotubercidin 100 µg 200.2
Cayman CAC-10010375-250 5-Iodotubercidin 250 µg 446.6
Cayman CAC-10010375-5 5-Iodotubercidin 5 mg 4004
Cayman CAC-10010376-1 FABP Assay Detection Reagent (5X) 1 ea 785.4
Cayman CAC-10010377-1 Arachidonic Acid Control 1 ea 2170.8
Cayman CAC-10010380-100 ent-8-iso-15(S)-Prostaglandin F2α 100 µg 5436.2
Cayman CAC-10010380-25 ent-8-iso-15(S)-Prostaglandin F2α 25 µg 1509.2
Cayman CAC-10010380-50 ent-8-iso-15(S)-Prostaglandin F2α 50 µg 2864.4
Cayman CAC-10010383-10 PtdIns-(3,4,5)-P3-fluorescein (ammonium salt) 10 µg 1062.6
Cayman CAC-10010383-100 PtdIns-(3,4,5)-P3-fluorescein (ammonium salt) 100 µg 8500.8
Cayman CAC-10010383-25 PtdIns-(3,4,5)-P3-fluorescein (ammonium salt) 25 µg 2525.6
Cayman CAC-10010383-50 PtdIns-(3,4,5)-P3-fluorescein (ammonium salt) 50 µg 4789.4
Cayman CAC-10010388-10 PtdIns-(4,5)-P2-fluorescein (ammonium salt) 10 µg 1062.6
Cayman CAC-10010388-100 PtdIns-(4,5)-P2-fluorescein (ammonium salt) 100 µg 8500.8
Cayman CAC-10010388-25 PtdIns-(4,5)-P2-fluorescein (ammonium salt) 25 µg 2525.6
Cayman CAC-10010388-50 PtdIns-(4,5)-P2-fluorescein (ammonium salt) 50 µg 4789.4
Cayman CAC-10010396-1 CAY10535 1 mg 554.4
Cayman CAC-10010396-10 CAY10535 10 mg 4435.2
Cayman CAC-10010396-5 CAY10535 5 mg 2494.8
Cayman CAC-10010396-50 CAY10535 50 mg 19404
Cayman CAC-10010398-10 CB-13 10 mg 1262.8
Cayman CAC-10010398-25 CB-13 25 mg 2987.6
Cayman CAC-10010398-5 CB-13 5 mg 662.2
Cayman CAC-10010398-50 CB-13 50 mg 5297.6
Cayman CAC-10010399-10 SB 202190 10 mg 385
Cayman CAC-10010399-25 SB 202190 25 mg 739.2
Cayman CAC-10010400-10 CAY10571 10 mg 1078
Cayman CAC-10010400-25 CAY10571 25 mg 2571.8
Cayman CAC-10010400-5 CAY10571 5 mg 569.8
Cayman CAC-10010401-96 SIRT1 Direct Fluorescent Screening Assay Kit 96 wells 5220
Cayman CAC-10010405-1 15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide 1 mg 847
Cayman CAC-10010405-10 15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide 10 mg 6776
Cayman CAC-10010405-25 15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide 25 mg 14830.2
Cayman CAC-10010405-5 15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide 5 mg 3819.2
Cayman CAC-10010406-1 Fluprostenol methyl amide 1 mg 862.4
Cayman CAC-10010406-10 Fluprostenol methyl amide 10 mg 6899.2
Cayman CAC-10010406-5 Fluprostenol methyl amide 5 mg 3880.8
Cayman CAC-10010410-1 GW 848687X 1 mg 2109.8
Cayman CAC-10010410-5 GW 848687X 5 mg 8870.4
Cayman CAC-10010410-500 GW 848687X 500 µg 1108.8
Cayman CAC-10010411-1 NS-304 1 mg 554.4
Cayman CAC-10010411-10 NS-304 10 mg 4435.2
Cayman CAC-10010411-5 NS-304 5 mg 2494.8
Cayman CAC-10010411-50 NS-304 50 mg 19404
Cayman CAC-10010412-1 MRE-269 1 mg 1154.4
Cayman CAC-10010412-10 MRE-269 10 mg 5035.2
Cayman CAC-10010412-5 MRE-269 5 mg 3094.8
Cayman CAC-10010412-50 MRE-269 50 mg 20004
Cayman CAC-10010421-10 Zaprinast 10 mg 323.4
Cayman CAC-10010421-100 Zaprinast 100 mg 2587.2
Cayman CAC-10010421-250 Zaprinast 250 mg 5667.2
Cayman CAC-10010421-50 Zaprinast 50 mg 1463
Cayman CAC-10010422-10 Nilotinib 10 mg 446.6
Cayman CAC-10010422-25 Nilotinib 25 mg 908.6
Cayman CAC-10010422-5 Nilotinib 5 mg 292.6
Cayman CAC-10010422-50 Nilotinib 50 mg 1478.4
Cayman CAC-10010425-1 13,14-dihydro-15-keto Prostaglandin D1 1 mg 1555.4
Cayman CAC-10010425-10 13,14-dihydro-15-keto Prostaglandin D1 10 mg 12443.2
Cayman CAC-10010425-5 13,14-dihydro-15-keto Prostaglandin D1 5 mg 7007
Cayman CAC-10010428-10 CJ-42794 10 mg 600.6
Cayman CAC-10010428-100 CJ-42794 100 mg 4804.8
Cayman CAC-10010428-250 CJ-42794 250 mg 9009
Cayman CAC-10010428-50 CJ-42794 50 mg 2710.4
Cayman CAC-10010460-1 17-chlorophenyl trinor Prostaglandin F2α ethyl amide 1 mg 1078
Cayman CAC-10010460-10 17-chlorophenyl trinor Prostaglandin F2α ethyl amide 10 mg 8624
Cayman CAC-10010460-5 17-chlorophenyl trinor Prostaglandin F2α ethyl amide 5 mg 4851
Cayman CAC-10010466-10 SP 600125 10 mg 816.2
Cayman CAC-10010466-25 SP 600125 25 mg 1355.2
Cayman CAC-10010466-5 SP 600125 5 mg 539
Cayman CAC-10010466-50 SP 600125 50 mg 2433.2
Cayman CAC-10010468-1 15-Lipoxygenase Inhibitor 1 1 mg 739.2
Cayman CAC-10010468-10 15-Lipoxygenase Inhibitor 1 10 mg 5390
Cayman CAC-10010468-5 15-Lipoxygenase Inhibitor 1 5 mg 3080
Cayman CAC-10010468-500 15-Lipoxygenase Inhibitor 1 500 µg 385
Cayman CAC-10010469-1 10-Acetyl-3,7-dihydroxyphenoxazine 1 mg 169.4
Cayman CAC-10010469-10 10-Acetyl-3,7-dihydroxyphenoxazine 10 mg 1355.2
Cayman CAC-10010469-25 10-Acetyl-3,7-dihydroxyphenoxazine 25 mg 2972.2
Cayman CAC-10010469-5 10-Acetyl-3,7-dihydroxyphenoxazine 5 mg 770
Cayman CAC-10010470-1 AL 8810 ethyl amide 1 mg 939.4
Cayman CAC-10010470-10 AL 8810 ethyl amide 10 mg 7515.2
Cayman CAC-10010470-5 AL 8810 ethyl amide 5 mg 4235
Cayman CAC-10010484-1 5(Z),14(Z)-Eicosadienoic Acid 1 mg 8377.6
Cayman CAC-10010484-100 5(Z),14(Z)-Eicosadienoic Acid 100 µg 1047.2
Cayman CAC-10010484-500 5(Z),14(Z)-Eicosadienoic Acid 500 µg 4712.4
Cayman CAC-10010486-100 14,15-EE-8(Z)-E 100 µg 2109.8
Cayman CAC-10010486-25 14,15-EE-8(Z)-E 25 µg 585.2
Cayman CAC-10010486-50 14,15-EE-8(Z)-E 50 µg 1108.8
Cayman CAC-10010486-500 14,15-EE-8(Z)-E 500 µg 9363.2
Cayman CAC-10010494-10 2-PCPA (hydrochloride) 10 mg 154
Cayman CAC-10010494-100 2-PCPA (hydrochloride) 100 mg 616
Cayman CAC-10010494-250 2-PCPA (hydrochloride) 250 mg 970.2
Cayman CAC-10010494-50 2-PCPA (hydrochloride) 50 mg 385
Cayman CAC-10010495-1 (+)-Cloprostenol methyl amide 1 mg 862.4
Cayman CAC-10010495-10 (+)-Cloprostenol methyl amide 10 mg 6899.2
Cayman CAC-10010495-5 (+)-Cloprostenol methyl amide 5 mg 3880.8
Cayman CAC-10010497-1 Manumycin A 1 mg 1232
Cayman CAC-10010497-5 Manumycin A 5 mg 5544
Cayman CAC-10010499-1 Prostaglandin A2-biotin 1 mg 3572.8
Cayman CAC-10010499-100 Prostaglandin A2-biotin 100 µg 446.6
Cayman CAC-10010499-500 Prostaglandin A2-biotin 500 µg 2017.4
Cayman CAC-10010500-100 8-iso Prostaglandin A2-biotin 100 µg 1401.4
Cayman CAC-10010500-50 8-iso Prostaglandin A2-biotin 50 µg 739.2
Cayman CAC-10010500-500 8-iso Prostaglandin A2-biotin 500 µg 5913.6
Cayman CAC-10010501-10 Farnesyl Thiosalicylic Acid 10 mg 893.2
Cayman CAC-10010501-25 Farnesyl Thiosalicylic Acid 25 mg 2094.4
Cayman CAC-10010501-5 Farnesyl Thiosalicylic Acid 5 mg 492.8
Cayman CAC-10010501-50 Farnesyl Thiosalicylic Acid 50 mg 3942.4
Cayman CAC-10010502-10 CAY10562 10 mg 739.2
Cayman CAC-10010502-100 CAY10562 100 mg 5390
Cayman CAC-10010502-25 CAY10562 25 mg 1740.2
Cayman CAC-10010502-5 CAY10562 5 mg 385
Cayman CAC-10010511-1 Triglyceride Enzyme Mixture (15X) 1 ea 2695
Cayman CAC-10010516-10 TMP-153 10 mg 693
Cayman CAC-10010516-25 TMP-153 25 mg 1062.6
Cayman CAC-10010516-5 TMP-153 5 mg 385
Cayman CAC-10010517-10 BIBB 515 10 mg 924
Cayman CAC-10010517-100 BIBB 515 100 mg 5929
Cayman CAC-10010517-5 BIBB 515 5 mg 539
Cayman CAC-10010517-50 BIBB 515 50 mg 3773
Cayman CAC-10010518-10 PD 146176 10 mg 1108.8
Cayman CAC-10010518-25 PD 146176 25 mg 2633.4
Cayman CAC-10010518-5 PD 146176 5 mg 585.2
Cayman CAC-10010518-50 PD 146176 50 mg 4681.6
Cayman CAC-10010519-1 Vialinin A 1 mg 708.4
Cayman CAC-10010519-10 Vialinin A 10 mg 5667.2
Cayman CAC-10010519-25 Vialinin A 25 mg 12397
Cayman CAC-10010519-5 Vialinin A 5 mg 3187.8
Cayman CAC-10010521-1 Palmitoyl thio-PC 1 mg 1416.8
Cayman CAC-10010521-10 Palmitoyl thio-PC 10 mg 11334.4
Cayman CAC-10010521-5 Palmitoyl thio-PC 5 mg 6375.6
Cayman CAC-10010522-1 U-46619 Glycine methyl ester 1 mg 7546
Cayman CAC-10010522-100 U-46619 Glycine methyl ester 100 µg 1031.8
Cayman CAC-10010522-50 U-46619 Glycine methyl ester 50 µg 539
Cayman CAC-10010522-500 U-46619 Glycine methyl ester 500 µg 4312
Cayman CAC-10010526-10 CAY10563 10 mg 739.2
Cayman CAC-10010526-100 CAY10563 100 mg 5390
Cayman CAC-10010526-25 CAY10563 25 mg 1740.2
Cayman CAC-10010526-5 CAY10563 5 mg 385
Cayman CAC-10010527-10 CAY10564 10 mg 739.2
Cayman CAC-10010527-100 CAY10564 100 mg 5390
Cayman CAC-10010527-25 CAY10564 25 mg 1740.2
Cayman CAC-10010527-5 CAY10564 5 mg 385
Cayman CAC-10010528-10 CAY10565 10 mg 739.2
Cayman CAC-10010528-100 CAY10565 100 mg 5390
Cayman CAC-10010528-25 CAY10565 25 mg 1740.2
Cayman CAC-10010528-5 CAY10565 5 mg 385
Cayman CAC-10010530-1 CD4 Monoclonal FITC Antibody (Clone RIV7) 1 ea 4450.6
Cayman CAC-10010541-10 L-threo-Sphingosine C-18 10 mg 2926
Cayman CAC-10010541-100 L-threo-Sphingosine C-18 100 mg 21560
Cayman CAC-10010541-5 L-threo-Sphingosine C-18 5 mg 1540
Cayman CAC-10010541-50 L-threo-Sphingosine C-18 50 mg 12320
Cayman CAC-10010547-10 O-Arachidonoyl Glycidol 10 mg 1925
Cayman CAC-10010547-100 O-Arachidonoyl Glycidol 100 mg 14229.6
Cayman CAC-10010547-5 O-Arachidonoyl Glycidol 5 mg 1016.4
Cayman CAC-10010547-50 O-Arachidonoyl Glycidol 50 mg 8131.2
Cayman CAC-10010556-10 H-89 (hydrochloride) 10 mg 1139.6
Cayman CAC-10010556-25 H-89 (hydrochloride) 25 mg 2710.4
Cayman CAC-10010556-5 H-89 (hydrochloride) 5 mg 600.6
Cayman CAC-10010556-50 H-89 (hydrochloride) 50 mg 4512.2
Cayman CAC-10010559-10 HA-1077 (hydrochloride) 10 mg 385
Cayman CAC-10010559-100 HA-1077 (hydrochloride) 100 mg 1740.2
Cayman CAC-10010559-50 HA-1077 (hydrochloride) 50 mg 1062.6
Cayman CAC-10010562-1 16-phenoxy tetranor Prostaglandin F2α methyl amide 1 mg 1262.8
Cayman CAC-10010562-5 16-phenoxy tetranor Prostaglandin F2α methyl amide 5 mg 5297.6
Cayman CAC-10010562-500 16-phenoxy tetranor Prostaglandin F2α methyl amide 500 µg 662.2
Cayman CAC-10010564-100 Pyrimidine-4-Carboxylic Acid 100 mg 415.8
Cayman CAC-10010564-250 Pyrimidine-4-Carboxylic Acid 250 mg 970.2
Cayman CAC-10010564-50 Pyrimidine-4-Carboxylic Acid 50 mg 215.6
Cayman CAC-10010564-500 Pyrimidine-4-Carboxylic Acid 500 mg 1724.8
Cayman CAC-10010566-1 Albumin (bovine) Acetylated 1 ea 770
Cayman CAC-10010567-1 Acetyl Lysine Monoclonal Antibody (Clone 7F8) 1 ea 4604.6
Cayman CAC-10010568-1 AG-370 1 mg 693
Cayman CAC-10010568-10 AG-370 10 mg 5544
Cayman CAC-10010568-25 AG-370 25 mg 12135.2
Cayman CAC-10010568-5 AG-370 5 mg 3126.2
Cayman CAC-10010569-10 Acenocoumarol 10 mg 693
Cayman CAC-10010569-100 Acenocoumarol 100 mg 5544
Cayman CAC-10010569-25 Acenocoumarol 25 mg 1647.8
Cayman CAC-10010569-50 Acenocoumarol 50 mg 3126.2
Cayman CAC-10010587-1 N-Desmethyl Sildenafil (citrate) 1 mg 770
Cayman CAC-10010587-10 N-Desmethyl Sildenafil (citrate) 10 mg 5390
Cayman CAC-10010587-5 N-Desmethyl Sildenafil (citrate) 5 mg 3234
Cayman CAC-10010591-1 Wortmannin 1 mg 539
Cayman CAC-10010591-10 Wortmannin 10 mg 2541
Cayman CAC-10010591-5 Wortmannin 5 mg 1478.4
Cayman CAC-10010592-1 AG-1296 1 mg 323.4
Cayman CAC-10010592-10 AG-1296 10 mg 2587.2
Cayman CAC-10010592-25 AG-1296 25 mg 5667.2
Cayman CAC-10010592-5 AG-1296 5 mg 1463
Cayman CAC-10010605-1 17-phenyl trinor Prostaglandin F2α cyclopropyl amide 1 mg 908.6
Cayman CAC-10010605-10 17-phenyl trinor Prostaglandin F2α cyclopropyl amide 10 mg 7268.8
Cayman CAC-10010605-5 17-phenyl trinor Prostaglandin F2α cyclopropyl amide 5 mg 4096.4
Cayman CAC-10010606-100 13,14-dihydro-15-keto Prostaglandin E2-d4 100 µg 4881.8
Cayman CAC-10010606-25 13,14-dihydro-15-keto Prostaglandin E2-d4 25 µg 1355.2
Cayman CAC-10010606-50 13,14-dihydro-15-keto Prostaglandin E2-d4 50 µg 2571.8
Cayman CAC-10010606-500 13,14-dihydro-15-keto Prostaglandin E2-d4 500 µg 21683.2
Cayman CAC-10010622-10 Genipin 10 mg 385
Cayman CAC-10010622-25 Genipin 25 mg 908.6
Cayman CAC-10010622-5 Genipin 5 mg 200.2
Cayman CAC-10010622-50 Genipin 50 mg 1601.6
Cayman CAC-10010623-1 Linoleic Acid-biotin 1 mg 5544
Cayman CAC-10010623-100 Linoleic Acid-biotin 100 µg 693
Cayman CAC-10010623-500 Linoleic Acid-biotin 500 µg 3126.2
Cayman CAC-10010624-1 Oleic Acid-biotin 1 mg 5544
Cayman CAC-10010624-100 Oleic Acid-biotin 100 µg 693
Cayman CAC-10010624-500 Oleic Acid-biotin 500 µg 3126.2
Cayman CAC-10010630-100 Latrunculin A 100 µg 1601.6
Cayman CAC-10010630-25 Latrunculin A 25 µg 446.6
Cayman CAC-10010630-50 Latrunculin A 50 µg 847
Cayman CAC-10010630-500 Latrunculin A 500 µg 7145.6
Cayman CAC-10010631-100 Latrunculin B 100 µg 708.4
Cayman CAC-10010631-250 Latrunculin B 250 µg 1663.2
Cayman CAC-10010631-50 Latrunculin B 50 µg 369.6
Cayman CAC-10010631-500 Latrunculin B 500 µg 2956.8
Cayman CAC-10010635-100 (±)16-HETE 100 µg 6652.8
Cayman CAC-10010635-25 (±)16-HETE 25 µg 1848
Cayman CAC-10010635-50 (±)16-HETE 50 µg 3511.2
Cayman CAC-10010636-100 (±)17-HETE 100 µg 6652.8
Cayman CAC-10010636-25 (±)17-HETE 25 µg 1848
Cayman CAC-10010636-50 (±)17-HETE 50 µg 3511.2
Cayman CAC-10010637-100 17(R)-HETE 100 µg 6652.8
Cayman CAC-10010637-25 17(R)-HETE 25 µg 1848
Cayman CAC-10010637-50 17(R)-HETE 50 µg 3511.2
Cayman CAC-10010638-100 (±)18-HETE 100 µg 6652.8
Cayman CAC-10010638-25 (±)18-HETE 25 µg 1848
Cayman CAC-10010638-50 (±)18-HETE 50 µg 3511.2
Cayman CAC-10010682-1 5'-deoxy-5-Fluorocytidine 1 g 1463
Cayman CAC-10010682-5 5'-deoxy-5-Fluorocytidine 5 g 5005
Cayman CAC-10010682-500 5'-deoxy-5-Fluorocytidine 500 mg 770
Cayman CAC-10010706-10 (-)-Deguelin 10 mg 1555.4
Cayman CAC-10010706-25 (-)-Deguelin 25 mg 3680.6
Cayman CAC-10010706-5 (-)-Deguelin 5 mg 816.2
Cayman CAC-10010706-50 (-)-Deguelin 50 mg 6529.6
Cayman CAC-10010712-500 CB2 Receptor Polyclonal FITC Antibody 500 µl 4296.6
Cayman CAC-10010721-1 S-Glutathionylated Protein Detection Kit 1 ea 4620
Cayman CAC-10010723-1 17-phenoxy trinor Prostaglandin F2α isopropyl ester 1 mg 785.4
Cayman CAC-10010723-10 17-phenoxy trinor Prostaglandin F2α isopropyl ester 10 mg 6283.2
Cayman CAC-10010723-5 17-phenoxy trinor Prostaglandin F2α isopropyl ester 5 mg 3542
Cayman CAC-10010726-1 PSSG Assay Buffer (10X) 1 ea 169.4
Cayman CAC-10010727-1 PSSG Blocking Reagent 1 ea 292.6
Cayman CAC-10010728-1 PSSG Lysis Buffer 1 ea 169.4
Cayman CAC-10010729-1 PSSG Reduction Reagent 1 ea 708.4
Cayman CAC-10010731-1 PSSG Labeling Reagent 1 ea 292.6
Cayman CAC-10010732-1 PSSG Detection Reagent I (HRP) 1 ea 554.4
Cayman CAC-10010733-1 PSSG Detection Reagent II (FITC) 1 ea 554.4
Cayman CAC-10010740-1 CAY10550 1 mg 323.4
Cayman CAC-10010740-10 CAY10550 10 mg 2587.2
Cayman CAC-10010740-25 CAY10550 25 mg 5667.2
Cayman CAC-10010740-5 CAY10550 5 mg 1463
Cayman CAC-10010742-1 17-phenoxy trinor Prostaglandin F2α ethyl amide 1 mg 1078
Cayman CAC-10010742-10 17-phenoxy trinor Prostaglandin F2α ethyl amide 10 mg 8624
Cayman CAC-10010742-5 17-phenoxy trinor Prostaglandin F2α ethyl amide 5 mg 4851
Cayman CAC-10010743-10 Capsaicin (technical grade) 10 g 5005
Cayman CAC-10010743-1 Capsaicin (technical grade) 1 g 739.2
Cayman CAC-10010743-500 Capsaicin (technical grade) 500 mg 385
Cayman CAC-10010743-5 Capsaicin (technical grade) 5 g 2695
Cayman CAC-10010744-1 SC-51322 1 mg 231
Cayman CAC-10010744-10 SC-51322 10 mg 1848
Cayman CAC-10010744-25 SC-51322 25 mg 4050.2
Cayman CAC-10010744-5 SC-51322 5 mg 1047.2
Cayman CAC-10010749-1 PIK-90 1 mg 215.6
Cayman CAC-10010749-10 PIK-90 10 mg 1062.6
Cayman CAC-10010749-5 PIK-90 5 mg 754.6
Cayman CAC-10010755-96 Glycerol Colorimetric Assay Kit 96 wells 3049.2
Cayman CAC-10010785-10 (±)-Lisofylline 10 mg 908.6
Cayman CAC-10010785-100 (±)-Lisofylline 100 mg 4928
Cayman CAC-10010785-25 (±)-Lisofylline 25 mg 1463
Cayman CAC-10010785-50 (±)-Lisofylline 50 mg 2772
Cayman CAC-10010809-1 16-phenoxy tetranor Prostaglandin F2α cyclopropyl methyl amide 1 mg 908.6
Cayman CAC-10010809-10 16-phenoxy tetranor Prostaglandin F2α cyclopropyl methyl amide 10 mg 7268.8
Cayman CAC-10010809-5 16-phenoxy tetranor Prostaglandin F2α cyclopropyl methyl amide 5 mg 4096.4
Cayman CAC-10010810-1 17-phenyl trinor Prostaglandin F2α cyclopropyl methyl amide 1 mg 908.6
Cayman CAC-10010810-10 17-phenyl trinor Prostaglandin F2α cyclopropyl methyl amide 10 mg 7268.8
Cayman CAC-10010810-5 17-phenyl trinor Prostaglandin F2α cyclopropyl methyl amide 5 mg 4096.4
Cayman CAC-10010811-1 Lutein 1 mg 924
Cayman CAC-10010811-10 Lutein 10 mg 5544
Cayman CAC-10010811-25 Lutein 25 mg 8085
Cayman CAC-10010811-5 Lutein 5 mg 3696
Cayman CAC-10010839-1 17-phenoxy trinor Prostaglandin F2α 1 mg 785.4
Cayman CAC-10010839-10 17-phenoxy trinor Prostaglandin F2α 10 mg 6283.2
Cayman CAC-10010839-5 17-phenoxy trinor Prostaglandin F2α 5 mg 3542
Cayman CAC-10010854-96 SREBP-1 Transcription Factor Assay Kit 96 wells 7145
Cayman CAC-10010893-1 Transcription Factor SREBP-1 Positive Control 1 ea 1601
Cayman CAC-10010894-1 Transcription Factor SREBP-1 Primary Antibody 1 ea 1201.2
Cayman CAC-10010895-96 Xanthine Oxidase Fluorometric Assay Kit 96 wells 1647.8
Cayman CAC-10010896-100 Protein Tyrosine Phosphatase 1B (human recombinant) 100 µg 4219
Cayman CAC-10010907-1 PF-622 1 mg 292.6
Cayman CAC-10010907-10 PF-622 10 mg 2340.8
Cayman CAC-10010907-5 PF-622 5 mg 1324.4
Cayman CAC-10010907-50 PF-622 50 mg 10241
Cayman CAC-10010908-1 PF-750 1 mg 200.2
Cayman CAC-10010908-10 PF-750 10 mg 1601.6
Cayman CAC-10010908-5 PF-750 5 mg 908.6
Cayman CAC-10010908-50 PF-750 50 mg 7007
Cayman CAC-10010947-10 β-cyano-L-Alanine 10 mg 77
Cayman CAC-10010947-100 β-cyano-L-Alanine 100 mg 616
Cayman CAC-10010947-250 β-cyano-L-Alanine 250 mg 1355.2
Cayman CAC-10010947-50 β-cyano-L-Alanine 50 mg 354.2
Cayman CAC-10010948-1 DL-Propargyl Glycine (hydrochloride) 1 mg 184.8
Cayman CAC-10010948-10 DL-Propargyl Glycine (hydrochloride) 10 mg 1478.4
Cayman CAC-10010948-5 DL-Propargyl Glycine (hydrochloride) 5 mg 831.6
Cayman CAC-10010948-50 DL-Propargyl Glycine (hydrochloride) 50 mg 6468
Cayman CAC-10010960-1 Glycerol Standard 1 ea 785.4
Cayman CAC-10010962-1 Glycerol Enzyme Mixture 1 ea 1570.8
Cayman CAC-10010965-100 KT 5823 100 µg 1555.4
Cayman CAC-10010965-25 KT 5823 25 µg 431.2
Cayman CAC-10010965-250 KT 5823 250 µg 3449.6
Cayman CAC-10010965-50 KT 5823 50 µg 816.2
Cayman CAC-10010972-1 Xanthine Oxidase Assay Buffer (10X) 1 ea 169.4
Cayman CAC-10010973-1 Xanthine Oxidase Sample Buffer (10X) 1 ea 169.4
Cayman CAC-10010974-1 Xanthine Oxidase Standard 1 ea 169.4
Cayman CAC-10010975-1 Xanthine Oxidase Detector 1 ea 246.4
Cayman CAC-10010976-1 Xanthine Oxidase Horseradish Peroxidase 1 ea 169.4
Cayman CAC-10010978-10 Diphenylphosphine isopropyl ester 10 mg 616
Cayman CAC-10010978-100 Diphenylphosphine isopropyl ester 100 mg 4527.6
Cayman CAC-10010978-5 Diphenylphosphine isopropyl ester 5 mg 323.4
Cayman CAC-10010978-50 Diphenylphosphine isopropyl ester 50 mg 2587.2
Cayman CAC-10010991-96 SIRT1 FRET-Based Screening Assay Kit 96 wells 5220
Cayman CAC-10010992-1 W123 1 mg 985.6
Cayman CAC-10010992-10 W123 10 mg 7884.8
Cayman CAC-10010992-25 W123 25 mg 17248
Cayman CAC-10010992-5 W123 5 mg 4435.2
Cayman CAC-10010993-1 SIRT1 Direct Assay Buffer (10X) 1 ea 769.4
Cayman CAC-10010994-1 SIRT1 (human recombinant) Direct Assay Reagent 1 ea 1000.4
Cayman CAC-10010995-1 SIRT1 Direct Peptide 1 ea 2016.8
Cayman CAC-10010996-1 SIRT1 Direct NAD+ 1 ea 769.4
Cayman CAC-10010997-1 SIRT1 Direct Nicotinamide 1 ea 769.4
Cayman CAC-10010998-1 SIRT1 Direct Developer 1 ea 1231.4
Cayman CAC-10010999-1 SIRT1 Direct Fluorophore 1 ea 769.4
Cayman CAC-10011011-100 KT 5720 100 µg 2017.4
Cayman CAC-10011011-250 KT 5720 250 µg 4789.4
Cayman CAC-10011011-50 KT 5720 50 µg 1062.6
Cayman CAC-10011011-500 KT 5720 500 µg 8500.8
Cayman CAC-10011018-1 Cell-Based Tamoxifen (100 mM) 1 ea 631.4
Cayman CAC-10011020-1 SRT 1720 (hydrochloride) 1 mg 446.6
Cayman CAC-10011020-10 SRT 1720 (hydrochloride) 10 mg 2233
Cayman CAC-10011020-5 SRT 1720 (hydrochloride) 5 mg 1447.6
Cayman CAC-10011020-50 SRT 1720 (hydrochloride) 50 mg 8932
Cayman CAC-10011032-100 QX-314 (bromide) 100 mg 1001
Cayman CAC-10011032-25 QX-314 (bromide) 25 mg 385
Cayman CAC-10011032-50 QX-314 (bromide) 50 mg 539
Cayman CAC-10011038-1 Hemopressin 1 mg 1925
Cayman CAC-10011048-10 2,3-dihydrothieno-Thiadiazole Carboxylate 10 mg 169.4
Cayman CAC-10011048-100 2,3-dihydrothieno-Thiadiazole Carboxylate 100 mg 1355.2
Cayman CAC-10011048-50 2,3-dihydrothieno-Thiadiazole Carboxylate 50 mg 770
Cayman CAC-10011051-1 Menaquinone-7 1 mg 1524.6
Cayman CAC-10011051-10 Menaquinone-7 10 mg 10672.2
Cayman CAC-10011051-5 Menaquinone-7 5 mg 6098.4
Cayman CAC-10011054-1 KB2115 1 mg 739.2
Cayman CAC-10011054-10 KB2115 10 mg 5390
Cayman CAC-10011054-5 KB2115 5 mg 3080
Cayman CAC-10011054-500 KB2115 500 µg 385
Cayman CAC-10011055-1 4-phenyl-1,2,3-Thiadiazole 1 g 939.4
Cayman CAC-10011055-250 4-phenyl-1,2,3-Thiadiazole 250 mg 261.8
Cayman CAC-10011055-5 4-phenyl-1,2,3-Thiadiazole 5 g 4188.8
Cayman CAC-10011055-500 4-phenyl-1,2,3-Thiadiazole 500 mg 492.8
Cayman CAC-10011056-1 3-O-methyl-N-acetyl-D-Glucosamine 1 mg 600.6
Cayman CAC-10011056-10 3-O-methyl-N-acetyl-D-Glucosamine 10 mg 2109.8
Cayman CAC-10011056-5 3-O-methyl-N-acetyl-D-Glucosamine 5 mg 1509.2
Cayman CAC-10011060-100 N-acetyl-D-Mannosamine 100 mg 107.8
Cayman CAC-10011060-1 N-acetyl-D-Mannosamine 1 g 862.4
Cayman CAC-10011060-250 N-acetyl-D-Mannosamine 250 mg 261.8
Cayman CAC-10011060-500 N-acetyl-D-Mannosamine 500 mg 492.8
Cayman CAC-10011080-1 SIRT1 FRET Assay Buffer (10X) 1 ea 769.4
Cayman CAC-10011081-1 SIRT1 (human recombinant) FRET Assay Reagent 1 ea 1231.4
Cayman CAC-10011082-1 SIRT1 FRET Peptide 1 ea 2016.8
Cayman CAC-10011083-1 SIRT1 FRET NAD+ 1 ea 769.4
Cayman CAC-10011084-1 SIRT1 FRET Stop Solution 1 ea 769.4
Cayman CAC-10011085-1 SIRT1 FRET Developer 1 ea 1231.4
Cayman CAC-10011086-1 SIRT1 FRET Fluorophore 1 ea 769.4
Cayman CAC-10011094-1 20S Proteasome Positive Control 1 ea 1616.4
Cayman CAC-10011095-1 20S Proteasome Substrate (SUC-LLVY-AMC) 1 ea 1108.8
Cayman CAC-10011096-1 Cell-Based Assay Epigallocatechin Gallate (EGCG) 1 ea 1108.8
Cayman CAC-10011097-1 20S Proteasome Assay Buffer 1 ea 631.4
Cayman CAC-10011098-1 20S Proteasome Lysis Buffer 1 ea 631.4
Cayman CAC-10011124-10 Trimidox (hydrochloride) 10 mg 1493.8
Cayman CAC-10011124-25 Trimidox (hydrochloride) 25 mg 3542
Cayman CAC-10011124-5 Trimidox (hydrochloride) 5 mg 785.4
Cayman CAC-10011124-50 Trimidox (hydrochloride) 50 mg 6283.2
Cayman CAC-10011125-1 LDL Uptake Cell-Based Assay Kit 1 ea 5482.4
Cayman CAC-10011126-1 Clobenpropit (hydrobromide) 1 mg 431.2
Cayman CAC-10011126-10 Clobenpropit (hydrobromide) 10 mg 3449.6
Cayman CAC-10011126-25 Clobenpropit (hydrobromide) 25 mg 7546
Cayman CAC-10011126-5 Clobenpropit (hydrobromide) 5 mg 1940.4
Cayman CAC-10011127-1 Thioperamide (maleate) 1 mg 154
Cayman CAC-10011127-10 Thioperamide (maleate) 10 mg 1232
Cayman CAC-10011127-25 Thioperamide (maleate) 25 mg 2695
Cayman CAC-10011127-5 Thioperamide (maleate) 5 mg 693
Cayman CAC-10011131-1 BAY 41-8543 1 mg 785.4
Cayman CAC-10011131-10 BAY 41-8543 10 mg 6283.2
Cayman CAC-10011131-25 BAY 41-8543 25 mg 13752.2
Cayman CAC-10011131-5 BAY 41-8543 5 mg 3542
Cayman CAC-10011132-10 Rolipram 10 mg 646.8
Cayman CAC-10011132-25 Rolipram 25 mg 1524.6
Cayman CAC-10011132-5 Rolipram 5 mg 338.8
Cayman CAC-10011133-10 Papaverine 10 mg 1155
Cayman CAC-10011133-100 Papaverine 100 mg 3465
Cayman CAC-10011133-50 Papaverine 50 mg 2017.4
Cayman CAC-10011135-1 BAY 60-7550 1 mg 1216.6
Cayman CAC-10011135-10 BAY 60-7550 10 mg 9732.8
Cayman CAC-10011135-5 BAY 60-7550 5 mg 5482.4
Cayman CAC-10011141-1 MG Phosphate Standard 1 ea 292.6
Cayman CAC-10011142-1 MG Blue Solution 1 ea 292.6
Cayman CAC-10011143-1 MG Acidic Solution 1 ea 292.6
Cayman CAC-10011144-1 96-Well Solid Plate (low volume) 1 ea 477.4
Cayman CAC-10011178-1 Arachidonoyl Ethanolamide-d4 1 mg 2510.2
Cayman CAC-10011178-10 Arachidonoyl Ethanolamide-d4 10 mg 18541.6
Cayman CAC-10011178-5 Arachidonoyl Ethanolamide-d4 5 mg 10595.2
Cayman CAC-10011178-500 Arachidonoyl Ethanolamide-d4 500 µg 1324.4
Cayman CAC-10011190-100 SIRT1 (human recombinant) 100 units 5528
Cayman CAC-10011191-100 SIRT2 (human recombinant) 100 µg 6067
Cayman CAC-10011194-100 SIRT3 (human recombinant) 100 µg 6067
Cayman CAC-10011198-10 N-heptanoyl-L-Homoserine lactone 10 mg 877.8
Cayman CAC-10011198-25 N-heptanoyl-L-Homoserine lactone 25 mg 2079
Cayman CAC-10011198-5 N-heptanoyl-L-Homoserine lactone 5 mg 462
Cayman CAC-10011198-50 N-heptanoyl-L-Homoserine lactone 50 mg 3696
Cayman CAC-10011199-10 N-octanoyl-L-Homoserine lactone 10 mg 908.6
Cayman CAC-10011199-25 N-octanoyl-L-Homoserine lactone 25 mg 2156
Cayman CAC-10011199-5 N-octanoyl-L-Homoserine lactone 5 mg 477.4
Cayman CAC-10011199-50 N-octanoyl-L-Homoserine lactone 50 mg 3819.2
Cayman CAC-10011200-10 N-tetradecanoyl-L-Homoserine lactone 10 mg 877.8
Cayman CAC-10011200-25 N-tetradecanoyl-L-Homoserine lactone 25 mg 2079
Cayman CAC-10011200-5 N-tetradecanoyl-L-Homoserine lactone 5 mg 462
Cayman CAC-10011200-50 N-tetradecanoyl-L-Homoserine lactone 50 mg 3696
Cayman CAC-10011201-10 N-decanoyl-L-Homoserine lactone 10 mg 877.8
Cayman CAC-10011201-25 N-decanoyl-L-Homoserine lactone 25 mg 2079
Cayman CAC-10011201-5 N-decanoyl-L-Homoserine lactone 5 mg 462
Cayman CAC-10011201-50 N-decanoyl-L-Homoserine lactone 50 mg 3696
Cayman CAC-10011203-10 N-dodecanoyl-L-Homoserine lactone 10 mg 877.8
Cayman CAC-10011203-25 N-dodecanoyl-L-Homoserine lactone 25 mg 2079
Cayman CAC-10011203-5 N-dodecanoyl-L-Homoserine lactone 5 mg 462
Cayman CAC-10011203-50 N-dodecanoyl-L-Homoserine lactone 50 mg 3696
Cayman CAC-10011204-10 N-butyryl-L-Homocysteine thiolactone 10 mg 754.6
Cayman CAC-10011204-25 N-butyryl-L-Homocysteine thiolactone 25 mg 1801.8
Cayman CAC-10011204-5 N-butyryl-L-Homocysteine thiolactone 5 mg 400.4
Cayman CAC-10011204-50 N-butyryl-L-Homocysteine thiolactone 50 mg 3203.2
Cayman CAC-10011206-10 N-3-oxo-octanoyl-L-Homoserine lactone 10 mg 816.2
Cayman CAC-10011206-25 N-3-oxo-octanoyl-L-Homoserine lactone 25 mg 1925
Cayman CAC-10011206-5 N-3-oxo-octanoyl-L-Homoserine lactone 5 mg 462
Cayman CAC-10011206-50 N-3-oxo-octanoyl-L-Homoserine lactone 50 mg 3388
Cayman CAC-10011207-10 N-(β-ketocaproyl)-L-Homoserine lactone 10 mg 677.6
Cayman CAC-10011207-25 N-(β-ketocaproyl)-L-Homoserine lactone 25 mg 1601.6
Cayman CAC-10011207-5 N-(β-ketocaproyl)-L-Homoserine lactone 5 mg 354.2
Cayman CAC-10011207-50 N-(β-ketocaproyl)-L-Homoserine lactone 50 mg 2833.6
Cayman CAC-10011211-1 GW 9578 1 mg 677.6
Cayman CAC-10011211-10 GW 9578 10 mg 4958.8
Cayman CAC-10011211-5 GW 9578 5 mg 2833.6
Cayman CAC-10011211-500 GW 9578 500 µg 354.2
Cayman CAC-10011213-1 WWL70 1 mg 554.4
Cayman CAC-10011213-10 WWL70 10 mg 2956.8
Cayman CAC-10011213-25 WWL70 25 mg 6468
Cayman CAC-10011213-5 WWL70 5 mg 1663.2
Cayman CAC-10011229-1 LDL-DyLightTM 550 1 ea 3126.2
Cayman CAC-10011231-1 DyLightTM 488-Conjugated Goat Anti-Rabbit IgG Secondary Antibody 1 ea 939.4
Cayman CAC-10011234-1 Cell-Based Propidium Iodide Solution 1 ea 939.4
Cayman CAC-10011236-96 C-Reactive Protein (human) ELISA Kit 96 wells 6039
Cayman CAC-10011237-10 Protein Phosphatase 2A C subunit (human recombinant; L309 deletion) 10 µg 4219
Cayman CAC-10011238-1 N-3-oxo-hexadec-11(Z)-enoyl-L-Homoserine lactone 1 mg 354.2
Cayman CAC-10011238-10 N-3-oxo-hexadec-11(Z)-enoyl-L-Homoserine lactone 10 mg 2833.6
Cayman CAC-10011238-25 N-3-oxo-hexadec-11(Z)-enoyl-L-Homoserine lactone 25 mg 6206.2
Cayman CAC-10011238-5 N-3-oxo-hexadec-11(Z)-enoyl-L-Homoserine lactone 5 mg 1601.6
Cayman CAC-10011246-1 Janex 1 1 mg 369.6
Cayman CAC-10011246-10 Janex 1 10 mg 2956.8
Cayman CAC-10011246-25 Janex 1 25 mg 6468
Cayman CAC-10011246-5 Janex 1 5 mg 1663.2
Cayman CAC-10011247-1 CAY10574 1 mg 292.6
Cayman CAC-10011247-10 CAY10574 10 mg 2340.8
Cayman CAC-10011247-5 CAY10574 5 mg 1324.4
Cayman CAC-10011247-50 CAY10574 50 mg 10241
Cayman CAC-10011248-1 CAY10575 1 mg 385
Cayman CAC-10011248-10 CAY10575 10 mg 3080
Cayman CAC-10011248-25 CAY10575 25 mg 6745.2
Cayman CAC-10011248-5 CAY10575 5 mg 1740.2
Cayman CAC-10011249-1 CAY10576 1 mg 554.4
Cayman CAC-10011249-10 CAY10576 10 mg 4435.2
Cayman CAC-10011249-5 CAY10576 5 mg 2494.8
產品咨詢